,aeid,Rosiglitazone_Maleate,Troglitazone,biological_process_target,intended_target_family,intended_target_family_sub,intended_target_gene_symbol,technological_target_gene_symbol,intended_target_entrez_gene_id,technological_target_entrez_gene_id,intended_target_gene_name,technological_target_gene_name,assay_component_endpoint_name
0,1,,83.2430592993927,cell proliferation,cell cycle,cytotoxicity,,,,,,,ACEA_T47D_80hr_Negative
1,2,,1000000.0,cell proliferation,nuclear receptor,steroidal,ESR1,,2099,,estrogen receptor 1,,ACEA_T47D_80hr_Positive
2,23,,76.0519141972514,cell cycle,cell cycle,proliferation,,,,,,,APR_HepG2_CellCycleArrest_24h_dn
3,24,,1000000.0,cell cycle,cell cycle,arrest,,,,,,,APR_HepG2_CellCycleArrest_24h_up
4,25,,101.695791313885,cell death,cell cycle,cytotoxicity,,,,,,,APR_HepG2_CellLoss_24h_dn
5,26,,1000000.0,cell death,cell cycle,proliferation,,,,,,,APR_HepG2_CellLoss_24h_up
6,27,,117.850629442189,protein stabilization,cell morphology,cell conformation,,TUBA1A,,7846,,"tubulin, alpha 1a",APR_HepG2_MicrotubuleCSK_24h_dn
7,28,,1000000.0,protein stabilization,cell morphology,cell conformation,,TUBA1A,,7846,,"tubulin, alpha 1a",APR_HepG2_MicrotubuleCSK_24h_up
8,29,,1000000.0,cell cycle,cell morphology,organelle conformation,,,,,,,APR_HepG2_MitoMass_24h_dn
9,30,,1000000.0,cell cycle,cell morphology,organelle conformation,,,,,,,APR_HepG2_MitoMass_24h_up
10,31,,91.3993057346858,mitochondrial depolarization,cell morphology,organelle conformation,,,,,,,APR_HepG2_MitoMembPot_24h_dn
11,32,,1000000.0,mitochondrial depolarization,cell morphology,organelle conformation,,,,,,,APR_HepG2_MitoMembPot_24h_up
12,33,,1000000.0,cell cycle,cell cycle,proliferation,,H3F3A,,3020,,"H3 histone, family 3A",APR_HepG2_MitoticArrest_24h_dn
13,34,,1000000.0,cell cycle,cell cycle,arrest,,H3F3A,,3020,,"H3 histone, family 3A",APR_HepG2_MitoticArrest_24h_up
14,35,,1000000.0,cell cycle,cell morphology,organelle conformation,,,,,,,APR_HepG2_NuclearSize_24h_dn
15,36,,1000000.0,cell cycle,cell morphology,organelle conformation,,,,,,,APR_HepG2_NuclearSize_24h_up
16,37,,1000000.0,oxidative phosphorylation,cell cycle,stress response,,H2AFX,,3014,,"H2A histone family, member X",APR_HepG2_OxidativeStress_24h_dn
17,38,,108.014611690844,oxidative phosphorylation,cell cycle,stress response,,H2AFX,,3014,,"H2A histone family, member X",APR_HepG2_OxidativeStress_24h_up
18,39,,1000000.0,cell death,dna binding,tumor suppressor,TP53,TP53,7157,7157,tumor protein p53,tumor protein p53,APR_HepG2_p53Act_24h_dn
19,40,,1000000.0,cell death,dna binding,tumor suppressor,TP53,TP53,7157,7157,tumor protein p53,tumor protein p53,APR_HepG2_p53Act_24h_up
20,41,,1000000.0,oxidative phosphorylation,cell cycle,stress response,,JUN,,3725,,jun proto-oncogene,APR_HepG2_StressKinase_24h_dn
21,42,,1000000.0,oxidative phosphorylation,cell cycle,stress response,,JUN,,3725,,jun proto-oncogene,APR_HepG2_StressKinase_24h_up
22,43,,1000000.0,cell cycle,cell cycle,proliferation,,,,,,,APR_HepG2_CellCycleArrest_72h_dn
23,44,,1000000.0,cell cycle,cell cycle,arrest,,,,,,,APR_HepG2_CellCycleArrest_72h_up
24,45,,88.4165725827255,cell death,cell cycle,cytotoxicity,,,,,,,APR_HepG2_CellLoss_72h_dn
25,46,,1000000.0,cell death,cell cycle,proliferation,,,,,,,APR_HepG2_CellLoss_72h_up
26,47,,1000000.0,protein stabilization,cell morphology,cell conformation,,TUBA1A,,7846,,"tubulin, alpha 1a",APR_HepG2_MicrotubuleCSK_72h_dn
27,48,,1000000.0,protein stabilization,cell morphology,cell conformation,,TUBA1A,,7846,,"tubulin, alpha 1a",APR_HepG2_MicrotubuleCSK_72h_up
28,49,,78.2090684680014,cell cycle,cell morphology,organelle conformation,,,,,,,APR_HepG2_MitoMass_72h_dn
29,50,,1000000.0,cell cycle,cell morphology,organelle conformation,,,,,,,APR_HepG2_MitoMass_72h_up
30,51,,106.575418851061,mitochondrial depolarization,cell morphology,organelle conformation,,,,,,,APR_HepG2_MitoMembPot_72h_dn
31,52,,1000000.0,mitochondrial depolarization,cell morphology,organelle conformation,,,,,,,APR_HepG2_MitoMembPot_72h_up
32,53,,1000000.0,cell cycle,cell cycle,proliferation,,H3F3A,,3020,,"H3 histone, family 3A",APR_HepG2_MitoticArrest_72h_dn
33,54,,60.2149301830274,cell cycle,cell cycle,arrest,,H3F3A,,3020,,"H3 histone, family 3A",APR_HepG2_MitoticArrest_72h_up
34,55,,1000000.0,cell cycle,cell morphology,organelle conformation,,,,,,,APR_HepG2_NuclearSize_72h_dn
35,56,,1000000.0,cell cycle,cell morphology,organelle conformation,,,,,,,APR_HepG2_NuclearSize_72h_up
36,57,,1000000.0,oxidative phosphorylation,cell cycle,stress response,,H2AFX,,3014,,"H2A histone family, member X",APR_HepG2_OxidativeStress_72h_dn
37,58,,91.8270636567261,oxidative phosphorylation,cell cycle,stress response,,H2AFX,,3014,,"H2A histone family, member X",APR_HepG2_OxidativeStress_72h_up
38,59,,1000000.0,cell death,dna binding,tumor suppressor,TP53,TP53,7157,7157,tumor protein p53,tumor protein p53,APR_HepG2_p53Act_72h_dn
39,60,,57.4748718053601,cell death,dna binding,tumor suppressor,TP53,TP53,7157,7157,tumor protein p53,tumor protein p53,APR_HepG2_p53Act_72h_up
40,61,,1000000.0,oxidative phosphorylation,cell cycle,stress response,,JUN,,3725,,jun proto-oncogene,APR_HepG2_StressKinase_72h_dn
41,62,,78.6709742028191,oxidative phosphorylation,cell cycle,stress response,,JUN,,3725,,jun proto-oncogene,APR_HepG2_StressKinase_72h_up
42,63,1000000.0,1000000.0,regulation of transcription factor activity,dna binding,basic helix-loop-helix protein,AHR,AHR,196,196,aryl hydrocarbon receptor,aryl hydrocarbon receptor,ATG_Ahr_CIS_up
43,1400,1000000.0,1000000.0,regulation of transcription factor activity,dna binding,basic helix-loop-helix protein,,AHR,,196,,aryl hydrocarbon receptor,ATG_Ahr_CIS_dn
44,64,1000000.0,8.05432782821354,regulation of transcription factor activity,dna binding,basic leucine zipper,JUN|FOS,JUN|FOS,3725|2353,3725|2353,jun proto-oncogene|FBJ murine osteosarcoma viral oncogene homolog,jun proto-oncogene|FBJ murine osteosarcoma viral oncogene homolog,ATG_AP_1_CIS_up
45,1401,1000000.0,1000000.0,regulation of transcription factor activity,dna binding,basic leucine zipper,,JUN|FOS,,3725|2353,,jun proto-oncogene|FBJ murine osteosarcoma viral oncogene homolog,ATG_AP_1_CIS_dn
46,65,1000000.0,1000000.0,regulation of transcription factor activity,dna binding,basic helix-turn-helix leucine zipper,TFAP2A|TFAP2B|TFAP2D,TFAP2A|TFAP2B|TFAP2D,7020|7021|83741,7020|7021|83741,transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha)|transcription factor AP-2 beta (activating enhancer binding protein 2 beta)|transcription factor AP-2 delta (activating enhancer binding protein 2 delta),transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha)|transcription factor AP-2 beta (activating enhancer binding protein 2 beta)|transcription factor AP-2 delta (activating enhancer binding protein 2 delta),ATG_AP_2_CIS_up
47,1402,1000000.0,1000000.0,regulation of transcription factor activity,dna binding,basic helix-turn-helix leucine zipper,,TFAP2A|TFAP2B|TFAP2D,,7020|7021|83741,,transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha)|transcription factor AP-2 beta (activating enhancer binding protein 2 beta)|transcription factor AP-2 delta (activating enhancer binding protein 2 delta),ATG_AP_2_CIS_dn
48,66,1000000.0,1000000.0,regulation of transcription factor activity,dna binding,Smad protein,SMAD1,SMAD1,4086,4086,SMAD family member 1,SMAD family member 1,ATG_BRE_CIS_up
49,1404,1000000.0,1000000.0,regulation of transcription factor activity,dna binding,Smad protein,,SMAD1,,4086,,SMAD family member 1,ATG_BRE_CIS_dn
50,67,1000000.0,1000000.0,regulation of transcription factor activity,dna binding,basic leucine zipper,CEBPB,CEBPB,1051,1051,"CCAAT/enhancer binding protein (C/EBP), beta","CCAAT/enhancer binding protein (C/EBP), beta",ATG_C_EBP_CIS_up
51,1410,1000000.0,1000000.0,regulation of transcription factor activity,dna binding,basic leucine zipper,,CEBPB,,1051,,"CCAAT/enhancer binding protein (C/EBP), beta",ATG_C_EBP_CIS_dn
52,68,1000000.0,8.67172371119819,regulation of transcription factor activity,background measurement,internal marker,,,,,,,ATG_CMV_CIS_up
53,1406,1000000.0,1000000.0,regulation of transcription factor activity,background measurement,internal marker,,,,,,,ATG_CMV_CIS_dn
54,69,1000000.0,1000000.0,regulation of transcription factor activity,dna binding,basic leucine zipper,CREB3,CREB3,10488,10488,cAMP responsive element binding protein 3,cAMP responsive element binding protein 3,ATG_CRE_CIS_up
55,1409,1000000.0,1000000.0,regulation of transcription factor activity,dna binding,basic leucine zipper,,CREB3,,10488,,cAMP responsive element binding protein 3,ATG_CRE_CIS_dn
56,70,1000000.0,1000000.0,regulation of transcription factor activity,nuclear receptor,non-steroidal,NR1H3|NR1H2,NR1H3|NR1H2,10062|7376,10062|7376,"nuclear receptor subfamily 1, group H, member 3|nuclear receptor subfamily 1, group H, member 2","nuclear receptor subfamily 1, group H, member 3|nuclear receptor subfamily 1, group H, member 2",ATG_DR4_LXR_CIS_up
57,1412,1000000.0,5.9111787422794,regulation of transcription factor activity,nuclear receptor,non-steroidal,,NR1H3|NR1H2,,10062|7376,,"nuclear receptor subfamily 1, group H, member 3|nuclear receptor subfamily 1, group H, member 2",ATG_DR4_LXR_CIS_dn
58,71,1000000.0,1000000.0,regulation of transcription factor activity,nuclear receptor,non-steroidal,RARA|RARB|RARG,RARA|RARB|RARG,5914|5915|5916,5914|5915|5916,"retinoic acid receptor, alpha|retinoic acid receptor, beta|retinoic acid receptor, gamma","retinoic acid receptor, alpha|retinoic acid receptor, beta|retinoic acid receptor, gamma",ATG_DR5_CIS_up
59,1413,1000000.0,1000000.0,regulation of transcription factor activity,nuclear receptor,non-steroidal,,RARA|RARB|RARG,,5914|5915|5916,,"retinoic acid receptor, alpha|retinoic acid receptor, beta|retinoic acid receptor, gamma",ATG_DR5_CIS_dn
60,72,1000000.0,6.55368919666757,regulation of transcription factor activity,dna binding,basic helix-loop-helix protein,USF1,USF1,7391,7391,upstream transcription factor 1,upstream transcription factor 1,ATG_E_Box_CIS_up
61,1424,1000000.0,1000000.0,regulation of transcription factor activity,dna binding,basic helix-loop-helix protein,,USF1,,7391,,upstream transcription factor 1,ATG_E_Box_CIS_dn
62,73,1000000.0,1000000.0,regulation of transcription factor activity,dna binding,E2F transcription factor,E2F1,E2F1,1869,1869,E2F transcription factor 1,E2F transcription factor 1,ATG_E2F_CIS_up
63,1414,1000000.0,6.56511696329019,regulation of transcription factor activity,dna binding,E2F transcription factor,,E2F1,,1869,,E2F transcription factor 1,ATG_E2F_CIS_dn
64,74,1000000.0,1000000.0,regulation of transcription factor activity,dna binding,zinc finger,EGR1,EGR1,1958,1958,early growth response 1,early growth response 1,ATG_EGR_CIS_up
65,1416,1000000.0,1000000.0,regulation of transcription factor activity,dna binding,zinc finger,,EGR1,,1958,,early growth response 1,ATG_EGR_CIS_dn
66,75,0.00800445492585763,0.226236145535942,regulation of transcription factor activity,nuclear receptor,steroidal,ESR1,ESR1,2099,2099,estrogen receptor 1,estrogen receptor 1,ATG_ERE_CIS_up
67,1419,1000000.0,1000000.0,regulation of transcription factor activity,nuclear receptor,steroidal,,ESR1,,2099,,estrogen receptor 1,ATG_ERE_CIS_dn
68,76,1000000.0,1000000.0,regulation of transcription factor activity,dna binding,winged helix-turn-helix,ETS1,ETS1,2113,2113,v-ets avian erythroblastosis virus E26 oncogene homolog 1,v-ets avian erythroblastosis virus E26 oncogene homolog 1,ATG_Ets_CIS_up
69,1423,1000000.0,1000000.0,regulation of transcription factor activity,dna binding,winged helix-turn-helix,,ETS1,,2113,,v-ets avian erythroblastosis virus E26 oncogene homolog 1,ATG_Ets_CIS_dn
70,77,1000000.0,1000000.0,regulation of transcription factor activity,dna binding,forkhead box protein,FOXA2,FOXA2,3170,3170,forkhead box A2,forkhead box A2,ATG_FoxA2_CIS_up
71,1425,57.1984545546524,1000000.0,regulation of transcription factor activity,dna binding,forkhead box protein,,FOXA2,,3170,,forkhead box A2,ATG_FoxA2_CIS_dn
72,78,1000000.0,1000000.0,regulation of transcription factor activity,dna binding,forkhead box protein,FOXO1|FOXO3,FOXO1|FOXO3,2308|2309,2308|2309,forkhead box O1|forkhead box O3,forkhead box O1|forkhead box O3,ATG_FoxO_CIS_up
73,1426,1000000.0,1000000.0,regulation of transcription factor activity,dna binding,forkhead box protein,,FOXO1|FOXO3,,2308|2309,,forkhead box O1|forkhead box O3,ATG_FoxO_CIS_dn
74,79,1000000.0,1000000.0,regulation of transcription factor activity,dna binding,GATA proteins,GATA1,GATA1,2623,2623,GATA binding protein 1 (globin transcription factor 1),GATA binding protein 1 (globin transcription factor 1),ATG_GATA_CIS_up
75,1429,1000000.0,1000000.0,regulation of transcription factor activity,dna binding,GATA proteins,,GATA1,,2623,,GATA binding protein 1 (globin transcription factor 1),ATG_GATA_CIS_dn
76,80,1000000.0,1000000.0,regulation of transcription factor activity,dna binding,zinc finger,GLI1,GLI1,2735,2735,GLI family zinc finger 1,GLI family zinc finger 1,ATG_GLI_CIS_up
77,1431,1000000.0,1000000.0,regulation of transcription factor activity,dna binding,zinc finger,,GLI1,,2735,,GLI family zinc finger 1,ATG_GLI_CIS_dn
78,81,1000000.0,1000000.0,regulation of transcription factor activity,nuclear receptor,steroidal,NR3C1,NR3C1,2908,2908,"nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)","nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)",ATG_GRE_CIS_up
79,1432,1000000.0,1000000.0,regulation of transcription factor activity,nuclear receptor,steroidal,,NR3C1,,2908,,"nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)",ATG_GRE_CIS_dn
80,82,1000000.0,1000000.0,regulation of transcription factor activity,dna binding,basic helix-loop-helix protein,HIF1A,HIF1A,3091,3091,"hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)","hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)",ATG_HIF1a_CIS_up
81,1434,1000000.0,1000000.0,regulation of transcription factor activity,dna binding,basic helix-loop-helix protein,,HIF1A,,3091,,"hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)",ATG_HIF1a_CIS_dn
82,83,1000000.0,1000000.0,regulation of transcription factor activity,dna binding,homeobox protein,ONECUT1,ONECUT1,3175,3175,one cut homeobox 1,one cut homeobox 1,ATG_HNF6_CIS_up
83,1437,1000000.0,1000000.0,regulation of transcription factor activity,dna binding,homeobox protein,,ONECUT1,,3175,,one cut homeobox 1,ATG_HNF6_CIS_dn
84,84,1000000.0,1000000.0,regulation of transcription factor activity,dna binding,heat shock protein,HSF1,HSF1,3297,3297,heat shock transcription factor 1,heat shock transcription factor 1,ATG_HSE_CIS_up
85,1439,1000000.0,1000000.0,regulation of transcription factor activity,dna binding,heat shock protein,,HSF1,,3297,,heat shock transcription factor 1,ATG_HSE_CIS_dn
86,85,1000000.0,1000000.0,regulation of transcription factor activity,nuclear receptor,non-steroidal,NR1H4,NR1H4,9971,9971,"nuclear receptor subfamily 1, group H, member 4","nuclear receptor subfamily 1, group H, member 4",ATG_IR1_CIS_up
87,1440,1000000.0,1000000.0,regulation of transcription factor activity,nuclear receptor,non-steroidal,,NR1H4,,9971,,"nuclear receptor subfamily 1, group H, member 4",ATG_IR1_CIS_dn
88,86,1000000.0,1000000.0,regulation of transcription factor activity,dna binding,interferon regulatory factors,IRF1,IRF1,3659,3659,interferon regulatory factor 1,interferon regulatory factor 1,ATG_ISRE_CIS_up
89,1441,1000000.0,1000000.0,regulation of transcription factor activity,dna binding,interferon regulatory factors,,IRF1,,3659,,interferon regulatory factor 1,ATG_ISRE_CIS_dn
90,87,1000000.0,1000000.0,regulation of transcription factor activity,background measurement,internal marker,,,,,,,ATG_M_06_CIS_up
91,1449,1000000.0,1000000.0,regulation of transcription factor activity,background measurement,internal marker,,,,,,,ATG_M_06_CIS_dn
92,88,1000000.0,1000000.0,regulation of transcription factor activity,background measurement,internal marker,,,,,,,ATG_M_19_CIS_up
93,1451,1000000.0,1000000.0,regulation of transcription factor activity,background measurement,internal marker,,,,,,,ATG_M_19_CIS_dn
94,89,1000000.0,1000000.0,regulation of transcription factor activity,background measurement,internal marker,,,,,,,ATG_M_32_CIS_up
95,1453,1000000.0,1000000.0,regulation of transcription factor activity,background measurement,internal marker,,,,,,,ATG_M_32_CIS_dn
96,90,1000000.0,1000000.0,regulation of transcription factor activity,background measurement,internal marker,,,,,,,ATG_M_61_CIS_up
97,1455,1000000.0,1000000.0,regulation of transcription factor activity,background measurement,internal marker,,,,,,,ATG_M_61_CIS_dn
98,91,1000000.0,16.3480069494158,regulation of transcription factor activity,dna binding,zinc finger,MTF1,MTF1,4520,4520,metal-regulatory transcription factor 1,metal-regulatory transcription factor 1,ATG_MRE_CIS_up
99,1445,1000000.0,1000000.0,regulation of transcription factor activity,dna binding,zinc finger,,MTF1,,4520,,metal-regulatory transcription factor 1,ATG_MRE_CIS_dn
100,92,1000000.0,1000000.0,regulation of transcription factor activity,dna binding,MYB proteins,MYB,MYB,4602,4602,v-myb avian myeloblastosis viral oncogene homolog,v-myb avian myeloblastosis viral oncogene homolog,ATG_Myb_CIS_up
101,1447,1000000.0,1000000.0,regulation of transcription factor activity,dna binding,MYB proteins,,MYB,,4602,,v-myb avian myeloblastosis viral oncogene homolog,ATG_Myb_CIS_dn
102,93,1000000.0,1000000.0,regulation of transcription factor activity,dna binding,basic helix-loop-helix leucine zipper,MYC,MYC,4609,4609,v-myc avian myelocytomatosis viral oncogene homolog,v-myc avian myelocytomatosis viral oncogene homolog,ATG_Myc_CIS_up
103,1448,1000000.0,1000000.0,regulation of transcription factor activity,dna binding,basic helix-loop-helix leucine zipper,,MYC,,4609,,v-myc avian myelocytomatosis viral oncogene homolog,ATG_Myc_CIS_dn
104,94,1000000.0,1000000.0,regulation of transcription factor activity,dna binding,NF-kappa B,NFKB1,NFKB1,4790,4790,nuclear factor of kappa light polypeptide gene enhancer in B-cells 1,nuclear factor of kappa light polypeptide gene enhancer in B-cells 1,ATG_NF_kB_CIS_up
105,1458,1000000.0,1000000.0,regulation of transcription factor activity,dna binding,NF-kappa B,,NFKB1,,4790,,nuclear factor of kappa light polypeptide gene enhancer in B-cells 1,ATG_NF_kB_CIS_dn
106,95,1000000.0,1000000.0,regulation of transcription factor activity,dna binding,nuclear factor I,NFIA,NFIA,4774,4774,nuclear factor I/A,nuclear factor I/A,ATG_NFI_CIS_up
107,1457,1000000.0,1000000.0,regulation of transcription factor activity,dna binding,nuclear factor I,,NFIA,,4774,,nuclear factor I/A,ATG_NFI_CIS_dn
108,96,1000000.0,1000000.0,regulation of transcription factor activity,dna binding,nuclear respiratory factors,NRF1,NRF1,4899,4899,nuclear respiratory factor 1,nuclear respiratory factor 1,ATG_NRF1_CIS_up
109,1460,1000000.0,1000000.0,regulation of transcription factor activity,dna binding,nuclear respiratory factors,,NRF1,,4899,,nuclear respiratory factor 1,ATG_NRF1_CIS_dn
110,97,17.8210239875345,9.66801110478665,regulation of transcription factor activity,dna binding,basic leucine zipper,NFE2L2,NFE2L2,4780,4780,"nuclear factor, erythroid 2-like 2","nuclear factor, erythroid 2-like 2",ATG_NRF2_ARE_CIS_up
111,1461,1000000.0,1000000.0,regulation of transcription factor activity,dna binding,basic leucine zipper,,NFE2L2,,4780,,"nuclear factor, erythroid 2-like 2",ATG_NRF2_ARE_CIS_dn
112,98,1000000.0,1000000.0,regulation of transcription factor activity,dna binding,POU domain protein,POU2F1,POU2F1,5451,5451,POU class 2 homeobox 1,POU class 2 homeobox 1,ATG_Oct_MLP_CIS_up
113,1464,1000000.0,1000000.0,regulation of transcription factor activity,dna binding,POU domain protein,,POU2F1,,5451,,POU class 2 homeobox 1,ATG_Oct_MLP_CIS_dn
114,99,1000000.0,1000000.0,regulation of transcription factor activity,dna binding,tumor suppressor,TP53,TP53,7157,7157,tumor protein p53,tumor protein p53,ATG_p53_CIS_up
115,1465,1000000.0,1000000.0,regulation of transcription factor activity,dna binding,tumor suppressor,,TP53,,7157,,tumor protein p53,ATG_p53_CIS_dn
116,100,1000000.0,1000000.0,regulation of transcription factor activity,dna binding,paired box protein,PAX6,PAX6,5080,5080,paired box 6,paired box 6,ATG_Pax6_CIS_up
117,1466,1000000.0,1000000.0,regulation of transcription factor activity,dna binding,paired box protein,,PAX6,,5080,,paired box 6,ATG_Pax6_CIS_dn
118,101,49.7633010372562,1000000.0,regulation of transcription factor activity,nuclear receptor,non-steroidal,NR1I3,NR1I3,9970,9970,"nuclear receptor subfamily 1, group I, member 3","nuclear receptor subfamily 1, group I, member 3",ATG_PBREM_CIS_up
119,1467,1000000.0,1000000.0,regulation of transcription factor activity,nuclear receptor,non-steroidal,,NR1I3,,9970,,"nuclear receptor subfamily 1, group I, member 3",ATG_PBREM_CIS_dn
120,102,0.00800000000102339,0.0835220664289543,regulation of transcription factor activity,nuclear receptor,non-steroidal,PPARA|PPARD|PPARG,PPARA|PPARD|PPARG,5465|5467|5468,5465|5467|5468,peroxisome proliferator-activated receptor alpha|peroxisome proliferator-activated receptor delta|peroxisome proliferator-activated receptor gamma,peroxisome proliferator-activated receptor alpha|peroxisome proliferator-activated receptor delta|peroxisome proliferator-activated receptor gamma,ATG_PPRE_CIS_up
121,1472,1000000.0,1000000.0,regulation of transcription factor activity,nuclear receptor,non-steroidal,,PPARA|PPARD|PPARG,,5465|5467|5468,,peroxisome proliferator-activated receptor alpha|peroxisome proliferator-activated receptor delta|peroxisome proliferator-activated receptor gamma,ATG_PPRE_CIS_dn
122,103,5.42870866813587,1.78534435441659,regulation of transcription factor activity,nuclear receptor,non-steroidal,NR1I2,NR1I2,8856,8856,"nuclear receptor subfamily 1, group I, member 2","nuclear receptor subfamily 1, group I, member 2",ATG_PXRE_CIS_up
123,1474,1000000.0,1000000.0,regulation of transcription factor activity,nuclear receptor,non-steroidal,,NR1I2,,8856,,"nuclear receptor subfamily 1, group I, member 2",ATG_PXRE_CIS_dn
124,104,7.41901758351122,9.0323703790621,regulation of transcription factor activity,nuclear receptor,orphan,RORA|RORB|RORC,RORA|RORB|RORC,6095|6096|6097,6095|6096|6097,RAR-related orphan receptor A|RAR-related orphan receptor B|RAR-related orphan receptor C,RAR-related orphan receptor A|RAR-related orphan receptor B|RAR-related orphan receptor C,ATG_RORE_CIS_up
125,1483,1000000.0,1000000.0,regulation of transcription factor activity,nuclear receptor,orphan,,RORA|RORB|RORC,,6095|6096|6097,,RAR-related orphan receptor A|RAR-related orphan receptor B|RAR-related orphan receptor C,ATG_RORE_CIS_dn
126,105,1000000.0,1000000.0,regulation of transcription factor activity,dna binding,HMG box protein,SOX1,SOX1,6656,6656,SRY (sex determining region Y)-box 1,SRY (sex determining region Y)-box 1,ATG_Sox_CIS_up
127,1490,1000000.0,1000000.0,regulation of transcription factor activity,dna binding,HMG box protein,,SOX1,,6656,,SRY (sex determining region Y)-box 1,ATG_Sox_CIS_dn
128,106,1000000.0,1000000.0,regulation of transcription factor activity,dna binding,zinc finger,SP1,SP1,6667,6667,Sp1 transcription factor,Sp1 transcription factor,ATG_Sp1_CIS_up
129,1491,1000000.0,1000000.0,regulation of transcription factor activity,dna binding,zinc finger,,SP1,,6667,,Sp1 transcription factor,ATG_Sp1_CIS_dn
130,107,5.55049295896916,2.05116674381167,regulation of transcription factor activity,dna binding,basic helix-loop-helix leucine zipper,SREBF1,SREBF1,6720,6720,sterol regulatory element binding transcription factor 1,sterol regulatory element binding transcription factor 1,ATG_SREBP_CIS_up
131,1492,1000000.0,1000000.0,regulation of transcription factor activity,dna binding,basic helix-loop-helix leucine zipper,,SREBF1,,6720,,sterol regulatory element binding transcription factor 1,ATG_SREBP_CIS_dn
132,108,1000000.0,1000000.0,regulation of transcription factor activity,dna binding,stat protein,STAT3,STAT3,6774,6774,signal transducer and activator of transcription 3 (acute-phase response factor),signal transducer and activator of transcription 3 (acute-phase response factor),ATG_STAT3_CIS_up
133,1493,1000000.0,1000000.0,regulation of transcription factor activity,dna binding,stat protein,,STAT3,,6774,,signal transducer and activator of transcription 3 (acute-phase response factor),ATG_STAT3_CIS_dn
134,109,1000000.0,1000000.0,regulation of transcription factor activity,background measurement,internal marker,,,,,,,ATG_TA_CIS_up
135,1495,1000000.0,1000000.0,regulation of transcription factor activity,background measurement,internal marker,,,,,,,ATG_TA_CIS_dn
136,110,1000000.0,1000000.0,regulation of transcription factor activity,background measurement,internal marker,,,,,,,ATG_TAL_CIS_up
137,1494,1000000.0,1000000.0,regulation of transcription factor activity,background measurement,internal marker,,,,,,,ATG_TAL_CIS_dn
138,111,1000000.0,1000000.0,regulation of transcription factor activity,dna binding,HMG box protein,LEF1|TCF7|TCF7L1|TCF7L2,LEF1|TCF7|TCF7L1|TCF7L2,51176|6932|83439|6934,51176|6932|83439|6934,"lymphoid enhancer-binding factor 1|transcription factor 7 (T-cell specific, HMG-box)|transcription factor 7-like 1 (T-cell specific, HMG-box)|transcription factor 7-like 2 (T-cell specific, HMG-box)","lymphoid enhancer-binding factor 1|transcription factor 7 (T-cell specific, HMG-box)|transcription factor 7-like 1 (T-cell specific, HMG-box)|transcription factor 7-like 2 (T-cell specific, HMG-box)",ATG_TCF_b_cat_CIS_up
139,1496,1000000.0,16.3633159218276,regulation of transcription factor activity,dna binding,HMG box protein,,LEF1|TCF7|TCF7L1|TCF7L2,,51176|6932|83439|6934,,"lymphoid enhancer-binding factor 1|transcription factor 7 (T-cell specific, HMG-box)|transcription factor 7-like 1 (T-cell specific, HMG-box)|transcription factor 7-like 2 (T-cell specific, HMG-box)",ATG_TCF_b_cat_CIS_dn
140,112,1000000.0,1000000.0,regulation of transcription factor activity,growth factor,transforming growth factor beta,TGFB1,TGFB1,7040,7040,"transforming growth factor, beta 1","transforming growth factor, beta 1",ATG_TGFb_CIS_up
141,1497,1000000.0,1000000.0,regulation of transcription factor activity,growth factor,transforming growth factor beta,,TGFB1,,7040,,"transforming growth factor, beta 1",ATG_TGFb_CIS_dn
142,113,16.8477432454253,8.28579935808832,regulation of transcription factor activity,nuclear receptor,non-steroidal,VDR,VDR,7421,7421,"vitamin D (1,25- dihydroxyvitamin D3) receptor","vitamin D (1,25- dihydroxyvitamin D3) receptor",ATG_VDRE_CIS_up
143,1503,1000000.0,1000000.0,regulation of transcription factor activity,nuclear receptor,non-steroidal,,VDR,,7421,,"vitamin D (1,25- dihydroxyvitamin D3) receptor",ATG_VDRE_CIS_dn
144,114,1000000.0,1000000.0,regulation of transcription factor activity,dna binding,basic leucine zipper,XBP1,XBP1,7494,7494,X-box binding protein 1,X-box binding protein 1,ATG_Xbp1_CIS_up
145,1505,1000000.0,1000000.0,regulation of transcription factor activity,dna binding,basic leucine zipper,,XBP1,,7494,,X-box binding protein 1,ATG_Xbp1_CIS_dn
146,115,1000000.0,1000000.0,regulation of transcription factor activity,nuclear receptor,steroidal,AR,AR,367,367,androgen receptor,androgen receptor,ATG_AR_TRANS_up
147,1403,1000000.0,1000000.0,regulation of transcription factor activity,nuclear receptor,steroidal,,AR,,367,,androgen receptor,ATG_AR_TRANS_dn
148,116,1000000.0,1000000.0,regulation of transcription factor activity,nuclear receptor,non-steroidal,NR1I3,NR1I3,9970,9970,"nuclear receptor subfamily 1, group I, member 3","nuclear receptor subfamily 1, group I, member 3",ATG_CAR_TRANS_up
149,1405,1000000.0,1000000.0,regulation of transcription factor activity,nuclear receptor,non-steroidal,,NR1I3,,9970,,"nuclear receptor subfamily 1, group I, member 3",ATG_CAR_TRANS_dn
150,117,1000000.0,5.41625361620265,regulation of transcription factor activity,nuclear receptor,steroidal,ESR1,ESR1,2099,2099,estrogen receptor 1,estrogen receptor 1,ATG_ERa_TRANS_up
151,1417,1000000.0,1000000.0,regulation of transcription factor activity,nuclear receptor,steroidal,,ESR1,,2099,,estrogen receptor 1,ATG_ERa_TRANS_dn
152,118,1000000.0,1000000.0,regulation of transcription factor activity,nuclear receptor,steroidal,ESRRA,ESRRA,2101,2101,estrogen-related receptor alpha,estrogen-related receptor alpha,ATG_ERRa_TRANS_up
153,1420,1000000.0,1000000.0,regulation of transcription factor activity,nuclear receptor,steroidal,,ESRRA,,2101,,estrogen-related receptor alpha,ATG_ERRa_TRANS_dn
154,119,1000000.0,1000000.0,regulation of transcription factor activity,nuclear receptor,steroidal,ESRRG,ESRRG,2104,2104,estrogen-related receptor gamma,estrogen-related receptor gamma,ATG_ERRg_TRANS_up
155,1422,1000000.0,1000000.0,regulation of transcription factor activity,nuclear receptor,steroidal,,ESRRG,,2104,,estrogen-related receptor gamma,ATG_ERRg_TRANS_dn
156,120,31.5133690234594,16.2238698943722,regulation of transcription factor activity,nuclear receptor,non-steroidal,NR1H4,NR1H4,9971,9971,"nuclear receptor subfamily 1, group H, member 4","nuclear receptor subfamily 1, group H, member 4",ATG_FXR_TRANS_up
157,1427,1000000.0,1000000.0,regulation of transcription factor activity,nuclear receptor,non-steroidal,,NR1H4,,9971,,"nuclear receptor subfamily 1, group H, member 4",ATG_FXR_TRANS_dn
158,121,1000000.0,1000000.0,regulation of transcription factor activity,background measurement,baseline control,,GAL4,,855828,,Gal4p,ATG_GAL4_TRANS_up
159,1428,1000000.0,1000000.0,regulation of transcription factor activity,background measurement,baseline control,,GAL4,,855828,,Gal4p,ATG_GAL4_TRANS_dn
160,122,1000000.0,1000000.0,regulation of transcription factor activity,nuclear receptor,steroidal,NR3C1,NR3C1,2908,2908,"nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)","nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)",ATG_GR_TRANS_up
161,1433,1000000.0,1000000.0,regulation of transcription factor activity,nuclear receptor,steroidal,,NR3C1,,2908,,"nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)",ATG_GR_TRANS_dn
162,123,1000000.0,1000000.0,regulation of transcription factor activity,nuclear receptor,orphan,HNF4A,HNF4A,3172,3172,"hepatocyte nuclear factor 4, alpha","hepatocyte nuclear factor 4, alpha",ATG_HNF4a_TRANS_up
163,1435,1000000.0,1000000.0,regulation of transcription factor activity,nuclear receptor,orphan,,HNF4A,,3172,,"hepatocyte nuclear factor 4, alpha",ATG_HNF4a_TRANS_dn
164,125,1000000.0,1000000.0,regulation of transcription factor activity,nuclear receptor,non-steroidal,NR1H3,NR1H3,10062,10062,"nuclear receptor subfamily 1, group H, member 3","nuclear receptor subfamily 1, group H, member 3",ATG_LXRa_TRANS_up
165,1443,1000000.0,1000000.0,regulation of transcription factor activity,nuclear receptor,non-steroidal,,NR1H3,,10062,,"nuclear receptor subfamily 1, group H, member 3",ATG_LXRa_TRANS_dn
166,126,1000000.0,1000000.0,regulation of transcription factor activity,nuclear receptor,non-steroidal,NR1H2,NR1H2,7376,7376,"nuclear receptor subfamily 1, group H, member 2","nuclear receptor subfamily 1, group H, member 2",ATG_LXRb_TRANS_up
167,1444,1000000.0,1000000.0,regulation of transcription factor activity,nuclear receptor,non-steroidal,,NR1H2,,7376,,"nuclear receptor subfamily 1, group H, member 2",ATG_LXRb_TRANS_dn
168,127,1000000.0,1000000.0,regulation of transcription factor activity,background measurement,internal marker,,,,,,,ATG_M_06_TRANS_up
169,1450,1000000.0,1000000.0,regulation of transcription factor activity,background measurement,internal marker,,,,,,,ATG_M_06_TRANS_dn
170,128,1000000.0,1000000.0,regulation of transcription factor activity,background measurement,internal marker,,,,,,,ATG_M_19_TRANS_up
171,1452,1000000.0,1000000.0,regulation of transcription factor activity,background measurement,internal marker,,,,,,,ATG_M_19_TRANS_dn
172,129,1000000.0,1000000.0,regulation of transcription factor activity,background measurement,internal marker,,,,,,,ATG_M_32_TRANS_up
173,1454,1000000.0,1000000.0,regulation of transcription factor activity,background measurement,internal marker,,,,,,,ATG_M_32_TRANS_dn
174,130,1000000.0,1000000.0,regulation of transcription factor activity,background measurement,internal marker,,,,,,,ATG_M_61_TRANS_up
175,1456,1000000.0,1000000.0,regulation of transcription factor activity,background measurement,internal marker,,,,,,,ATG_M_61_TRANS_dn
176,131,1000000.0,1000000.0,regulation of transcription factor activity,nuclear receptor,orphan,NR4A2,NR4A2,4929,4929,"nuclear receptor subfamily 4, group A, member 2","nuclear receptor subfamily 4, group A, member 2",ATG_NURR1_TRANS_up
177,1463,1000000.0,1000000.0,regulation of transcription factor activity,nuclear receptor,orphan,,NR4A2,,4929,,"nuclear receptor subfamily 4, group A, member 2",ATG_NURR1_TRANS_dn
178,132,4.69765466942883,1000000.0,regulation of transcription factor activity,nuclear receptor,non-steroidal,PPARA,PPARA,5465,5465,peroxisome proliferator-activated receptor alpha,peroxisome proliferator-activated receptor alpha,ATG_PPARa_TRANS_up
179,1469,1000000.0,1000000.0,regulation of transcription factor activity,nuclear receptor,non-steroidal,,PPARA,,5465,,peroxisome proliferator-activated receptor alpha,ATG_PPARa_TRANS_dn
180,133,1000000.0,1000000.0,regulation of transcription factor activity,nuclear receptor,non-steroidal,PPARD,PPARD,5467,5467,peroxisome proliferator-activated receptor delta,peroxisome proliferator-activated receptor delta,ATG_PPARd_TRANS_up
181,1470,1000000.0,1000000.0,regulation of transcription factor activity,nuclear receptor,non-steroidal,,PPARD,,5467,,peroxisome proliferator-activated receptor delta,ATG_PPARd_TRANS_dn
182,134,0.0139712047065726,0.154710938505264,regulation of transcription factor activity,nuclear receptor,non-steroidal,PPARG,PPARG,5468,5468,peroxisome proliferator-activated receptor gamma,peroxisome proliferator-activated receptor gamma,ATG_PPARg_TRANS_up
183,1471,1000000.0,1000000.0,regulation of transcription factor activity,nuclear receptor,non-steroidal,,PPARG,,5468,,peroxisome proliferator-activated receptor gamma,ATG_PPARg_TRANS_dn
184,135,5.68345560579966,2.80015257370663,regulation of transcription factor activity,nuclear receptor,non-steroidal,NR1I2,NR1I2,8856,8856,"nuclear receptor subfamily 1, group I, member 2","nuclear receptor subfamily 1, group I, member 2",ATG_PXR_TRANS_up
185,1475,1000000.0,1000000.0,regulation of transcription factor activity,nuclear receptor,non-steroidal,,NR1I2,,8856,,"nuclear receptor subfamily 1, group I, member 2",ATG_PXR_TRANS_dn
186,136,1000000.0,1000000.0,regulation of transcription factor activity,nuclear receptor,non-steroidal,RARA,RARA,5914,5914,"retinoic acid receptor, alpha","retinoic acid receptor, alpha",ATG_RARa_TRANS_up
187,1476,1000000.0,1000000.0,regulation of transcription factor activity,nuclear receptor,non-steroidal,,RARA,,5914,,"retinoic acid receptor, alpha",ATG_RARa_TRANS_dn
188,137,1000000.0,1000000.0,regulation of transcription factor activity,nuclear receptor,non-steroidal,RARB,RARB,5915,5915,"retinoic acid receptor, beta","retinoic acid receptor, beta",ATG_RARb_TRANS_up
189,1477,1000000.0,1000000.0,regulation of transcription factor activity,nuclear receptor,non-steroidal,,RARB,,5915,,"retinoic acid receptor, beta",ATG_RARb_TRANS_dn
190,138,1000000.0,1000000.0,regulation of transcription factor activity,nuclear receptor,non-steroidal,RARG,RARG,5916,5916,"retinoic acid receptor, gamma","retinoic acid receptor, gamma",ATG_RARg_TRANS_up
191,1478,1000000.0,1000000.0,regulation of transcription factor activity,nuclear receptor,non-steroidal,,RARG,,5916,,"retinoic acid receptor, gamma",ATG_RARg_TRANS_dn
192,139,1000000.0,1000000.0,regulation of transcription factor activity,nuclear receptor,orphan,RORB,RORB,6096,6096,RAR-related orphan receptor B,RAR-related orphan receptor B,ATG_RORb_TRANS_up
193,1482,1000000.0,1000000.0,regulation of transcription factor activity,nuclear receptor,orphan,,RORB,,6096,,RAR-related orphan receptor B,ATG_RORb_TRANS_dn
194,140,1000000.0,1000000.0,regulation of transcription factor activity,nuclear receptor,orphan,RORC,RORC,6097,6097,RAR-related orphan receptor C,RAR-related orphan receptor C,ATG_RORg_TRANS_up
195,1484,1000000.0,1000000.0,regulation of transcription factor activity,nuclear receptor,orphan,,RORC,,6097,,RAR-related orphan receptor C,ATG_RORg_TRANS_dn
196,141,1000000.0,1000000.0,regulation of transcription factor activity,nuclear receptor,non-steroidal,RXRA,RXRA,6256,6256,"retinoid X receptor, alpha","retinoid X receptor, alpha",ATG_RXRa_TRANS_up
197,1485,1000000.0,1000000.0,regulation of transcription factor activity,nuclear receptor,non-steroidal,,RXRA,,6256,,"retinoid X receptor, alpha",ATG_RXRa_TRANS_dn
198,142,1000000.0,1000000.0,regulation of transcription factor activity,nuclear receptor,non-steroidal,RXRB,RXRB,6257,6257,"retinoid X receptor, beta","retinoid X receptor, beta",ATG_RXRb_TRANS_up
199,1486,1000000.0,1000000.0,regulation of transcription factor activity,nuclear receptor,non-steroidal,,RXRB,,6257,,"retinoid X receptor, beta",ATG_RXRb_TRANS_dn
200,143,1000000.0,1000000.0,regulation of transcription factor activity,nuclear receptor,non-steroidal,THRA,THRA,7067,7067,"thyroid hormone receptor, alpha","thyroid hormone receptor, alpha",ATG_THRa1_TRANS_up
201,1498,1000000.0,1000000.0,regulation of transcription factor activity,nuclear receptor,non-steroidal,,THRA,,7067,,"thyroid hormone receptor, alpha",ATG_THRa1_TRANS_dn
202,144,1000000.0,1000000.0,regulation of transcription factor activity,nuclear receptor,non-steroidal,VDR,VDR,7421,7421,"vitamin D (1,25- dihydroxyvitamin D3) receptor","vitamin D (1,25- dihydroxyvitamin D3) receptor",ATG_VDR_TRANS_up
203,1504,1000000.0,1000000.0,regulation of transcription factor activity,nuclear receptor,non-steroidal,,VDR,,7421,,"vitamin D (1,25- dihydroxyvitamin D3) receptor",ATG_VDR_TRANS_dn
204,145,17.5387641894987,36.1497831792766,regulation of gene expression,cell adhesion molecules,selectins,SELE,SELE,6401,6401,selectin E,selectin E,BSK_3C_Eselectin_down
205,146,1000000.0,1000000.0,regulation of gene expression,cell adhesion molecules,selectins,SELE,SELE,6401,6401,selectin E,selectin E,BSK_3C_Eselectin_up
206,147,19.7887905017244,22.53607256335,regulation of gene expression,cell adhesion molecules,MHC Class II,HLA-DRA,HLA-DRA,3122,3122,"major histocompatibility complex, class II, DR alpha","major histocompatibility complex, class II, DR alpha",BSK_3C_HLADR_down
207,148,1000000.0,1000000.0,regulation of gene expression,cell adhesion molecules,MHC Class II,HLA-DRA,HLA-DRA,3122,3122,"major histocompatibility complex, class II, DR alpha","major histocompatibility complex, class II, DR alpha",BSK_3C_HLADR_up
208,149,1000000.0,33.4989808816956,regulation of gene expression,cell adhesion molecules,Immunoglobulin CAM,ICAM1,ICAM1,3383,3383,intercellular adhesion molecule 1,intercellular adhesion molecule 1,BSK_3C_ICAM1_down
209,150,1000000.0,1000000.0,regulation of gene expression,cell adhesion molecules,Immunoglobulin CAM,ICAM1,ICAM1,3383,3383,intercellular adhesion molecule 1,intercellular adhesion molecule 1,BSK_3C_ICAM1_up
210,151,1000000.0,13.2252719246261,regulation of gene expression,cytokine,interleukins,CXCL8,CXCL8,3576,3576,chemokine (C-X-C motif) ligand 8,chemokine (C-X-C motif) ligand 8,BSK_3C_IL8_down
211,152,1000000.0,1000000.0,regulation of gene expression,cytokine,interleukins,CXCL8,CXCL8,3576,3576,chemokine (C-X-C motif) ligand 8,chemokine (C-X-C motif) ligand 8,BSK_3C_IL8_up
212,153,0.761426662727004,23.656429638228,regulation of gene expression,cytokine,chemotactic factor,CCL2,CCL2,6347,6347,chemokine (C-C motif) ligand 2,chemokine (C-C motif) ligand 2,BSK_3C_MCP1_down
213,154,1000000.0,1000000.0,regulation of gene expression,cytokine,chemotactic factor,CCL2,CCL2,6347,6347,chemokine (C-C motif) ligand 2,chemokine (C-C motif) ligand 2,BSK_3C_MCP1_up
214,155,1000000.0,18.4415248390951,regulation of gene expression,cytokine,chemotactic factor,CXCL9,CXCL9,4283,4283,chemokine (C-X-C motif) ligand 9,chemokine (C-X-C motif) ligand 9,BSK_3C_MIG_down
215,156,1000000.0,1000000.0,regulation of gene expression,cytokine,chemotactic factor,CXCL9,CXCL9,4283,4283,chemokine (C-X-C motif) ligand 9,chemokine (C-X-C motif) ligand 9,BSK_3C_MIG_up
216,157,8.65678265502905,21.3740399702773,cell proliferation,cell cycle,cytotoxicity,,,,,,,BSK_3C_Proliferation_down
217,158,1000000.0,1000000.0,cell proliferation,cell cycle,proliferation,,,,,,,BSK_3C_Proliferation_up
218,159,1000000.0,16.0483921568066,cell death,cell cycle,cytotoxicity,,,,,,,BSK_3C_SRB_down
219,160,1000000.0,1000000.0,cell death,cell morphology,cell conformation,,,,,,,BSK_3C_SRB_up
220,161,1000000.0,1000000.0,regulation of gene expression,gpcr,rhodopsin-like receptor,THBD,THBD,7056,7056,thrombomodulin,thrombomodulin,BSK_3C_Thrombomodulin_down
221,162,1000000.0,1000000.0,regulation of gene expression,gpcr,rhodopsin-like receptor,THBD,THBD,7056,7056,thrombomodulin,thrombomodulin,BSK_3C_Thrombomodulin_up
222,163,1000000.0,35.3343507807152,regulation of gene expression,cytokine,coagulation factor,F3,F3,2152,2152,"coagulation factor III (thromboplastin, tissue factor)","coagulation factor III (thromboplastin, tissue factor)",BSK_3C_TissueFactor_down
223,164,1000000.0,1000000.0,regulation of gene expression,cytokine,coagulation factor,F3,F3,2152,2152,"coagulation factor III (thromboplastin, tissue factor)","coagulation factor III (thromboplastin, tissue factor)",BSK_3C_TissueFactor_up
224,165,9.0327295773652,19.183285757392,regulation of gene expression,cytokine,plasmogen activator,PLAUR,PLAUR,5329,5329,"plasminogen activator, urokinase receptor","plasminogen activator, urokinase receptor",BSK_3C_uPAR_down
225,166,1000000.0,1000000.0,regulation of gene expression,cytokine,plasmogen activator,PLAUR,PLAUR,5329,5329,"plasminogen activator, urokinase receptor","plasminogen activator, urokinase receptor",BSK_3C_uPAR_up
226,167,1000000.0,28.1203719777199,regulation of gene expression,cell adhesion molecules,Immunoglobulin CAM,VCAM1,VCAM1,7412,7412,vascular cell adhesion molecule 1,vascular cell adhesion molecule 1,BSK_3C_VCAM1_down
227,168,1000000.0,1000000.0,regulation of gene expression,cell adhesion molecules,Immunoglobulin CAM,VCAM1,VCAM1,7412,7412,vascular cell adhesion molecule 1,vascular cell adhesion molecule 1,BSK_3C_VCAM1_up
228,169,1000000.0,11.9049348759399,cell morphology,cell morphology,cell conformation,,,,,,,BSK_3C_Vis_down
229,170,1000000.0,1000000.0,cell morphology,cell morphology,cell conformation,,,,,,,BSK_3C_Vis_up
230,171,6.06084884409157,14.9806167924231,regulation of gene expression,cytokine,chemotactic factor,CCL26,CCL26,10344,10344,chemokine (C-C motif) ligand 26,chemokine (C-C motif) ligand 26,BSK_4H_Eotaxin3_down
231,172,1000000.0,1000000.0,regulation of gene expression,cytokine,chemotactic factor,CCL26,CCL26,10344,10344,chemokine (C-C motif) ligand 26,chemokine (C-C motif) ligand 26,BSK_4H_Eotaxin3_up
232,173,5.30162949033877,8.21936560201376,regulation of gene expression,cytokine,chemotactic factor,CCL2,CCL2,6347,6347,chemokine (C-C motif) ligand 2,chemokine (C-C motif) ligand 2,BSK_4H_MCP1_down
233,174,1000000.0,1000000.0,regulation of gene expression,cytokine,chemotactic factor,CCL2,CCL2,6347,6347,chemokine (C-C motif) ligand 2,chemokine (C-C motif) ligand 2,BSK_4H_MCP1_up
234,175,2.46679593605536,10.6775627570159,regulation of gene expression,cell adhesion molecules,selectins,SELP,SELP,6403,6403,"selectin P (granule membrane protein 140kDa, antigen CD62)","selectin P (granule membrane protein 140kDa, antigen CD62)",BSK_4H_Pselectin_down
235,176,1000000.0,1000000.0,regulation of gene expression,cell adhesion molecules,selectins,SELP,SELP,6403,6403,"selectin P (granule membrane protein 140kDa, antigen CD62)","selectin P (granule membrane protein 140kDa, antigen CD62)",BSK_4H_Pselectin_up
236,177,10.5873153598809,29.7304000761494,cell death,cell cycle,cytotoxicity,,,,,,,BSK_4H_SRB_down
237,178,1000000.0,1000000.0,cell death,cell morphology,cell conformation,,,,,,,BSK_4H_SRB_up
238,179,10.3379044885296,21.6962356098982,regulation of gene expression,cytokine,plasmogen activator,PLAUR,PLAUR,5329,5329,"plasminogen activator, urokinase receptor","plasminogen activator, urokinase receptor",BSK_4H_uPAR_down
239,180,1000000.0,1000000.0,regulation of gene expression,cytokine,plasmogen activator,PLAUR,PLAUR,5329,5329,"plasminogen activator, urokinase receptor","plasminogen activator, urokinase receptor",BSK_4H_uPAR_up
240,181,8.44120730629049,27.6512446099971,regulation of gene expression,cell adhesion molecules,Immunoglobulin CAM,VCAM1,VCAM1,7412,7412,vascular cell adhesion molecule 1,vascular cell adhesion molecule 1,BSK_4H_VCAM1_down
241,182,1000000.0,1000000.0,regulation of gene expression,cell adhesion molecules,Immunoglobulin CAM,VCAM1,VCAM1,7412,7412,vascular cell adhesion molecule 1,vascular cell adhesion molecule 1,BSK_4H_VCAM1_up
242,183,1000000.0,1000000.0,regulation of gene expression,kinase,receptor tyrosine kinase,KDR,KDR,3791,3791,kinase insert domain receptor (a type III receptor tyrosine kinase),kinase insert domain receptor (a type III receptor tyrosine kinase),BSK_4H_VEGFRII_down
243,184,1000000.0,1000000.0,regulation of gene expression,kinase,receptor tyrosine kinase,KDR,KDR,3791,3791,kinase insert domain receptor (a type III receptor tyrosine kinase),kinase insert domain receptor (a type III receptor tyrosine kinase),BSK_4H_VEGFRII_up
244,185,17.9245155824329,11.7696504869309,regulation of gene expression,cell adhesion molecules,MHC Class II,HLA-DRA,HLA-DRA,3122,3122,"major histocompatibility complex, class II, DR alpha","major histocompatibility complex, class II, DR alpha",BSK_BE3C_HLADR_down
245,186,1000000.0,1000000.0,regulation of gene expression,cell adhesion molecules,MHC Class II,HLA-DRA,HLA-DRA,3122,3122,"major histocompatibility complex, class II, DR alpha","major histocompatibility complex, class II, DR alpha",BSK_BE3C_HLADR_up
246,187,3.56306341424277,13.4295333027523,regulation of gene expression,cytokine,interleukins,IL1A,IL1A,3552,3552,"interleukin 1, alpha","interleukin 1, alpha",BSK_BE3C_IL1a_down
247,188,1000000.0,1000000.0,regulation of gene expression,cytokine,interleukins,IL1A,IL1A,3552,3552,"interleukin 1, alpha","interleukin 1, alpha",BSK_BE3C_IL1a_up
248,189,16.5903333822603,10.9211689326802,regulation of gene expression,cytokine,chemotactic factor,CXCL10,CXCL10,3627,3627,chemokine (C-X-C motif) ligand 10,chemokine (C-X-C motif) ligand 10,BSK_BE3C_IP10_down
249,190,1000000.0,1000000.0,regulation of gene expression,cytokine,chemotactic factor,CXCL10,CXCL10,3627,3627,chemokine (C-X-C motif) ligand 10,chemokine (C-X-C motif) ligand 10,BSK_BE3C_IP10_up
250,191,1000000.0,15.1156665420594,regulation of gene expression,cytokine,chemotactic factor,CXCL9,CXCL9,4283,4283,chemokine (C-X-C motif) ligand 9,chemokine (C-X-C motif) ligand 9,BSK_BE3C_MIG_down
251,192,1000000.0,1000000.0,regulation of gene expression,cytokine,chemotactic factor,CXCL9,CXCL9,4283,4283,chemokine (C-X-C motif) ligand 9,chemokine (C-X-C motif) ligand 9,BSK_BE3C_MIG_up
252,193,1000000.0,33.2609787481841,regulation of gene expression,protease,matrix metalloproteinase,MMP1,MMP1,4312,4312,matrix metallopeptidase 1 (interstitial collagenase),matrix metallopeptidase 1 (interstitial collagenase),BSK_BE3C_MMP1_down
253,194,1000000.0,1000000.0,regulation of gene expression,protease,matrix metalloproteinase,MMP1,MMP1,4312,4312,matrix metallopeptidase 1 (interstitial collagenase),matrix metallopeptidase 1 (interstitial collagenase),BSK_BE3C_MMP1_up
254,195,0.236096703206216,11.3127278834004,regulation of gene expression,cytokine,plasmogen activator inhibitor,SERPINE1,SERPINE1,5054,5054,"serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1","serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1",BSK_BE3C_PAI1_down
255,196,1000000.0,1000000.0,regulation of gene expression,cytokine,plasmogen activator inhibitor,SERPINE1,SERPINE1,5054,5054,"serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1","serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1",BSK_BE3C_PAI1_up
256,197,1000000.0,22.2318856699011,cell death,cell cycle,cytotoxicity,,,,,,,BSK_BE3C_SRB_down
257,198,1000000.0,1000000.0,cell death,cell morphology,cell conformation,,,,,,,BSK_BE3C_SRB_up
258,199,1000000.0,12.0470079727886,regulation of gene expression,growth factor,transforming growth factor beta,TGFB1,TGFB1,7040,7040,"transforming growth factor, beta 1","transforming growth factor, beta 1",BSK_BE3C_TGFb1_down
259,200,1000000.0,1000000.0,regulation of gene expression,growth factor,transforming growth factor beta,TGFB1,TGFB1,7040,7040,"transforming growth factor, beta 1","transforming growth factor, beta 1",BSK_BE3C_TGFb1_up
260,201,1000000.0,8.72952934953297,regulation of gene expression,protease,serine protease,PLAT,PLAT,5327,5327,"plasminogen activator, tissue","plasminogen activator, tissue",BSK_BE3C_tPA_down
261,202,1000000.0,1000000.0,regulation of gene expression,protease,serine protease,PLAT,PLAT,5327,5327,"plasminogen activator, tissue","plasminogen activator, tissue",BSK_BE3C_tPA_up
262,203,1000000.0,11.8725312383604,regulation of gene expression,protease,serine protease,PLAU,PLAU,5328,5328,"plasminogen activator, urokinase","plasminogen activator, urokinase",BSK_BE3C_uPA_down
263,204,1000000.0,1000000.0,regulation of gene expression,protease,serine protease,PLAU,PLAU,5328,5328,"plasminogen activator, urokinase","plasminogen activator, urokinase",BSK_BE3C_uPA_up
264,205,5.05427647250063,13.9503173862074,regulation of gene expression,cytokine,plasmogen activator,PLAUR,PLAUR,5329,5329,"plasminogen activator, urokinase receptor","plasminogen activator, urokinase receptor",BSK_BE3C_uPAR_down
265,206,1000000.0,1000000.0,regulation of gene expression,cytokine,plasmogen activator,PLAUR,PLAUR,5329,5329,"plasminogen activator, urokinase receptor","plasminogen activator, urokinase receptor",BSK_BE3C_uPAR_up
266,207,1000000.0,1000000.0,regulation of gene expression,cell adhesion molecules,MHC Class II,HLA-DRA,HLA-DRA,3122,3122,"major histocompatibility complex, class II, DR alpha","major histocompatibility complex, class II, DR alpha",BSK_CASM3C_HLADR_down
267,208,1000000.0,1000000.0,regulation of gene expression,cell adhesion molecules,MHC Class II,HLA-DRA,HLA-DRA,3122,3122,"major histocompatibility complex, class II, DR alpha","major histocompatibility complex, class II, DR alpha",BSK_CASM3C_HLADR_up
268,209,1000000.0,1000000.0,regulation of gene expression,cytokine,interleukins,IL6,IL6,3569,3569,interleukin 6,interleukin 6,BSK_CASM3C_IL6_down
269,210,1000000.0,1000000.0,regulation of gene expression,cytokine,interleukins,IL6,IL6,3569,3569,interleukin 6,interleukin 6,BSK_CASM3C_IL6_up
270,211,1000000.0,1000000.0,regulation of gene expression,cytokine,interleukins,CXCL8,CXCL8,3576,3576,chemokine (C-X-C motif) ligand 8,chemokine (C-X-C motif) ligand 8,BSK_CASM3C_IL8_down
271,212,1000000.0,1000000.0,regulation of gene expression,cytokine,interleukins,CXCL8,CXCL8,3576,3576,chemokine (C-X-C motif) ligand 8,chemokine (C-X-C motif) ligand 8,BSK_CASM3C_IL8_up
272,213,1000000.0,1000000.0,regulation of gene expression,misc protein,LDL receptor,LDLR,LDLR,3949,3949,low density lipoprotein receptor,low density lipoprotein receptor,BSK_CASM3C_LDLR_down
273,214,8.87501184069395,1000000.0,regulation of gene expression,misc protein,LDL receptor,LDLR,LDLR,3949,3949,low density lipoprotein receptor,low density lipoprotein receptor,BSK_CASM3C_LDLR_up
274,215,1000000.0,1000000.0,regulation of gene expression,cytokine,chemotactic factor,CCL2,CCL2,6347,6347,chemokine (C-C motif) ligand 2,chemokine (C-C motif) ligand 2,BSK_CASM3C_MCP1_down
275,216,1000000.0,1000000.0,regulation of gene expression,cytokine,chemotactic factor,CCL2,CCL2,6347,6347,chemokine (C-C motif) ligand 2,chemokine (C-C motif) ligand 2,BSK_CASM3C_MCP1_up
276,217,1000000.0,1000000.0,regulation of gene expression,cytokine,colony stimulating factor,CSF1,CSF1,1435,1435,colony stimulating factor 1 (macrophage),colony stimulating factor 1 (macrophage),BSK_CASM3C_MCSF_down
277,218,1000000.0,1000000.0,regulation of gene expression,cytokine,colony stimulating factor,CSF1,CSF1,1435,1435,colony stimulating factor 1 (macrophage),colony stimulating factor 1 (macrophage),BSK_CASM3C_MCSF_up
278,219,1000000.0,1000000.0,regulation of gene expression,cytokine,chemotactic factor,CXCL9,CXCL9,4283,4283,chemokine (C-X-C motif) ligand 9,chemokine (C-X-C motif) ligand 9,BSK_CASM3C_MIG_down
279,220,1000000.0,1000000.0,regulation of gene expression,cytokine,chemotactic factor,CXCL9,CXCL9,4283,4283,chemokine (C-X-C motif) ligand 9,chemokine (C-X-C motif) ligand 9,BSK_CASM3C_MIG_up
280,221,1000000.0,5.40807506287699,cell proliferation,cell cycle,cytotoxicity,,,,,,,BSK_CASM3C_Proliferation_down
281,222,1000000.0,1000000.0,cell proliferation,cell cycle,proliferation,,,,,,,BSK_CASM3C_Proliferation_up
282,223,1000000.0,1000000.0,regulation of gene expression,cell adhesion molecules,apolipoproteins,SAA1,SAA1,6288,6288,serum amyloid A1,serum amyloid A1,BSK_CASM3C_SAA_down
283,224,1000000.0,1000000.0,regulation of gene expression,cell adhesion molecules,apolipoproteins,SAA1,SAA1,6288,6288,serum amyloid A1,serum amyloid A1,BSK_CASM3C_SAA_up
284,225,1000000.0,1000000.0,cell death,cell cycle,cytotoxicity,,,,,,,BSK_CASM3C_SRB_down
285,226,1000000.0,1000000.0,cell death,cell morphology,cell conformation,,,,,,,BSK_CASM3C_SRB_up
286,227,1000000.0,1000000.0,regulation of gene expression,gpcr,rhodopsin-like receptor,THBD,THBD,7056,7056,thrombomodulin,thrombomodulin,BSK_CASM3C_Thrombomodulin_down
287,228,1000000.0,4.57997435589914,regulation of gene expression,gpcr,rhodopsin-like receptor,THBD,THBD,7056,7056,thrombomodulin,thrombomodulin,BSK_CASM3C_Thrombomodulin_up
288,229,8.64038911010257,1000000.0,regulation of gene expression,cytokine,coagulation factor,F3,F3,2152,2152,"coagulation factor III (thromboplastin, tissue factor)","coagulation factor III (thromboplastin, tissue factor)",BSK_CASM3C_TissueFactor_down
289,230,1000000.0,1000000.0,regulation of gene expression,cytokine,coagulation factor,F3,F3,2152,2152,"coagulation factor III (thromboplastin, tissue factor)","coagulation factor III (thromboplastin, tissue factor)",BSK_CASM3C_TissueFactor_up
290,231,1000000.0,1000000.0,regulation of gene expression,cytokine,plasmogen activator,PLAUR,PLAUR,5329,5329,"plasminogen activator, urokinase receptor","plasminogen activator, urokinase receptor",BSK_CASM3C_uPAR_down
291,232,1000000.0,1000000.0,regulation of gene expression,cytokine,plasmogen activator,PLAUR,PLAUR,5329,5329,"plasminogen activator, urokinase receptor","plasminogen activator, urokinase receptor",BSK_CASM3C_uPAR_up
292,233,1000000.0,1000000.0,regulation of gene expression,cell adhesion molecules,Immunoglobulin CAM,VCAM1,VCAM1,7412,7412,vascular cell adhesion molecule 1,vascular cell adhesion molecule 1,BSK_CASM3C_VCAM1_down
293,234,1000000.0,1000000.0,regulation of gene expression,cell adhesion molecules,Immunoglobulin CAM,VCAM1,VCAM1,7412,7412,vascular cell adhesion molecule 1,vascular cell adhesion molecule 1,BSK_CASM3C_VCAM1_up
294,235,1000000.0,11.4438681966342,regulation of gene expression,cell adhesion molecules,collagen,COL3A1,COL3A1,1281,1281,"collagen, type III, alpha 1","collagen, type III, alpha 1",BSK_hDFCGF_CollagenIII_down
295,236,1000000.0,1000000.0,regulation of gene expression,cell adhesion molecules,collagen,COL3A1,COL3A1,1281,1281,"collagen, type III, alpha 1","collagen, type III, alpha 1",BSK_hDFCGF_CollagenIII_up
296,237,1000000.0,6.20027060263962,regulation of gene expression,kinase,receptor tyrosine kinase,EGFR,EGFR,1956,1956,epidermal growth factor receptor,epidermal growth factor receptor,BSK_hDFCGF_EGFR_down
297,238,1000000.0,1000000.0,regulation of gene expression,kinase,receptor tyrosine kinase,EGFR,EGFR,1956,1956,epidermal growth factor receptor,epidermal growth factor receptor,BSK_hDFCGF_EGFR_up
298,239,1000000.0,22.2770251097773,regulation of gene expression,cytokine,interleukins,CXCL8,CXCL8,3576,3576,chemokine (C-X-C motif) ligand 8,chemokine (C-X-C motif) ligand 8,BSK_hDFCGF_IL8_down
299,240,1000000.0,1000000.0,regulation of gene expression,cytokine,interleukins,CXCL8,CXCL8,3576,3576,chemokine (C-X-C motif) ligand 8,chemokine (C-X-C motif) ligand 8,BSK_hDFCGF_IL8_up
300,241,0.0122612740462744,7.47017904313418,regulation of gene expression,cytokine,chemotactic factor,CXCL10,CXCL10,3627,3627,chemokine (C-X-C motif) ligand 10,chemokine (C-X-C motif) ligand 10,BSK_hDFCGF_IP10_down
301,242,1000000.0,1000000.0,regulation of gene expression,cytokine,chemotactic factor,CXCL10,CXCL10,3627,3627,chemokine (C-X-C motif) ligand 10,chemokine (C-X-C motif) ligand 10,BSK_hDFCGF_IP10_up
302,243,0.152464778369646,8.81047695737142,regulation of gene expression,cytokine,colony stimulating factor,CSF1,CSF1,1435,1435,colony stimulating factor 1 (macrophage),colony stimulating factor 1 (macrophage),BSK_hDFCGF_MCSF_down
303,244,1000000.0,1000000.0,regulation of gene expression,cytokine,colony stimulating factor,CSF1,CSF1,1435,1435,colony stimulating factor 1 (macrophage),colony stimulating factor 1 (macrophage),BSK_hDFCGF_MCSF_up
304,245,1000000.0,11.8770785842479,regulation of gene expression,cytokine,chemotactic factor,CXCL9,CXCL9,4283,4283,chemokine (C-X-C motif) ligand 9,chemokine (C-X-C motif) ligand 9,BSK_hDFCGF_MIG_down
305,246,1000000.0,1000000.0,regulation of gene expression,cytokine,chemotactic factor,CXCL9,CXCL9,4283,4283,chemokine (C-X-C motif) ligand 9,chemokine (C-X-C motif) ligand 9,BSK_hDFCGF_MIG_up
306,247,1000000.0,20.4220359950884,regulation of gene expression,protease,matrix metalloproteinase,MMP1,MMP1,4312,4312,matrix metallopeptidase 1 (interstitial collagenase),matrix metallopeptidase 1 (interstitial collagenase),BSK_hDFCGF_MMP1_down
307,248,1000000.0,1000000.0,regulation of gene expression,protease,matrix metalloproteinase,MMP1,MMP1,4312,4312,matrix metallopeptidase 1 (interstitial collagenase),matrix metallopeptidase 1 (interstitial collagenase),BSK_hDFCGF_MMP1_up
308,249,1000000.0,6.76476411928534,regulation of gene expression,cytokine,plasmogen activator inhibitor,SERPINE1,SERPINE1,5054,5054,"serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1","serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1",BSK_hDFCGF_PAI1_down
309,250,1000000.0,1000000.0,regulation of gene expression,cytokine,plasmogen activator inhibitor,SERPINE1,SERPINE1,5054,5054,"serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1","serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1",BSK_hDFCGF_PAI1_up
310,251,10.0729057363102,5.28205538283262,cell proliferation,cell cycle,cytotoxicity,,,,,,,BSK_hDFCGF_Proliferation_down
311,252,1000000.0,1000000.0,cell proliferation,cell cycle,proliferation,,,,,,,BSK_hDFCGF_Proliferation_up
312,253,1000000.0,14.4644116397117,cell death,cell cycle,cytotoxicity,,,,,,,BSK_hDFCGF_SRB_down
313,254,1000000.0,1000000.0,cell death,cell morphology,cell conformation,,,,,,,BSK_hDFCGF_SRB_up
314,255,1000000.0,10.7195614800774,regulation of gene expression,protease inhibitor,metalloproteinase inhibitor,TIMP1,TIMP1,7076,7076,TIMP metallopeptidase inhibitor 1,TIMP metallopeptidase inhibitor 1,BSK_hDFCGF_TIMP1_down
315,256,1000000.0,1000000.0,regulation of gene expression,protease inhibitor,metalloproteinase inhibitor,TIMP1,TIMP1,7076,7076,TIMP metallopeptidase inhibitor 1,TIMP metallopeptidase inhibitor 1,BSK_hDFCGF_TIMP1_up
316,257,0.175618668962954,8.78301175626009,regulation of gene expression,cell adhesion molecules,Immunoglobulin CAM,VCAM1,VCAM1,7412,7412,vascular cell adhesion molecule 1,vascular cell adhesion molecule 1,BSK_hDFCGF_VCAM1_down
317,258,1000000.0,1000000.0,regulation of gene expression,cell adhesion molecules,Immunoglobulin CAM,VCAM1,VCAM1,7412,7412,vascular cell adhesion molecule 1,vascular cell adhesion molecule 1,BSK_hDFCGF_VCAM1_up
318,259,1000000.0,10.8078404692003,regulation of gene expression,cell adhesion molecules,Immunoglobulin CAM,ICAM1,ICAM1,3383,3383,intercellular adhesion molecule 1,intercellular adhesion molecule 1,BSK_KF3CT_ICAM1_down
319,260,1000000.0,1000000.0,regulation of gene expression,cell adhesion molecules,Immunoglobulin CAM,ICAM1,ICAM1,3383,3383,intercellular adhesion molecule 1,intercellular adhesion molecule 1,BSK_KF3CT_ICAM1_up
320,261,0.743046909459742,13.408702816551,regulation of gene expression,cytokine,interleukins,IL1A,IL1A,3552,3552,"interleukin 1, alpha","interleukin 1, alpha",BSK_KF3CT_IL1a_down
321,262,1000000.0,1000000.0,regulation of gene expression,cytokine,interleukins,IL1A,IL1A,3552,3552,"interleukin 1, alpha","interleukin 1, alpha",BSK_KF3CT_IL1a_up
322,263,1000000.0,8.3755129353182,regulation of gene expression,cytokine,chemotactic factor,CXCL10,CXCL10,3627,3627,chemokine (C-X-C motif) ligand 10,chemokine (C-X-C motif) ligand 10,BSK_KF3CT_IP10_down
323,264,2.10364848575103,1000000.0,regulation of gene expression,cytokine,chemotactic factor,CXCL10,CXCL10,3627,3627,chemokine (C-X-C motif) ligand 10,chemokine (C-X-C motif) ligand 10,BSK_KF3CT_IP10_up
324,265,1000000.0,10.7606634549199,regulation of gene expression,cytokine,chemotactic factor,CCL2,CCL2,6347,6347,chemokine (C-C motif) ligand 2,chemokine (C-C motif) ligand 2,BSK_KF3CT_MCP1_down
325,266,1000000.0,1000000.0,regulation of gene expression,cytokine,chemotactic factor,CCL2,CCL2,6347,6347,chemokine (C-C motif) ligand 2,chemokine (C-C motif) ligand 2,BSK_KF3CT_MCP1_up
326,267,4.53290503192459,9.24202104085219,regulation of gene expression,protease,matrix metalloproteinase,MMP9,MMP9,4318,4318,"matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)","matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)",BSK_KF3CT_MMP9_down
327,268,1000000.0,1000000.0,regulation of gene expression,protease,matrix metalloproteinase,MMP9,MMP9,4318,4318,"matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)","matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)",BSK_KF3CT_MMP9_up
328,269,1000000.0,10.6873792009146,cell death,cell cycle,cytotoxicity,,,,,,,BSK_KF3CT_SRB_down
329,270,1000000.0,1000000.0,cell death,cell morphology,cell conformation,,,,,,,BSK_KF3CT_SRB_up
330,271,0.00451424245477313,17.4265759732029,regulation of gene expression,growth factor,transforming growth factor beta,TGFB1,TGFB1,7040,7040,"transforming growth factor, beta 1","transforming growth factor, beta 1",BSK_KF3CT_TGFb1_down
331,272,1000000.0,1000000.0,regulation of gene expression,growth factor,transforming growth factor beta,TGFB1,TGFB1,7040,7040,"transforming growth factor, beta 1","transforming growth factor, beta 1",BSK_KF3CT_TGFb1_up
332,273,1000000.0,13.655723454251,regulation of gene expression,protease inhibitor,metalloproteinase inhibitor,TIMP2,TIMP2,7077,7077,TIMP metallopeptidase inhibitor 2,TIMP metallopeptidase inhibitor 2,BSK_KF3CT_TIMP2_down
333,274,1000000.0,1000000.0,regulation of gene expression,protease inhibitor,metalloproteinase inhibitor,TIMP2,TIMP2,7077,7077,TIMP metallopeptidase inhibitor 2,TIMP metallopeptidase inhibitor 2,BSK_KF3CT_TIMP2_up
334,275,0.037925250338418,9.19961348199197,regulation of gene expression,protease,serine protease,PLAU,PLAU,5328,5328,"plasminogen activator, urokinase","plasminogen activator, urokinase",BSK_KF3CT_uPA_down
335,276,1000000.0,1000000.0,regulation of gene expression,protease,serine protease,PLAU,PLAU,5328,5328,"plasminogen activator, urokinase","plasminogen activator, urokinase",BSK_KF3CT_uPA_up
336,277,9.61188676100047,12.3788458704642,regulation of gene expression,cytokine,inflammatory factor,CD40,CD40,958,958,"CD40 molecule, TNF receptor superfamily member 5","CD40 molecule, TNF receptor superfamily member 5",BSK_LPS_CD40_down
337,278,1000000.0,1000000.0,regulation of gene expression,cytokine,inflammatory factor,CD40,CD40,958,958,"CD40 molecule, TNF receptor superfamily member 5","CD40 molecule, TNF receptor superfamily member 5",BSK_LPS_CD40_up
338,279,1000000.0,15.838157360233,regulation of gene expression,cell adhesion molecules,selectins,SELE,SELE,6401,6401,selectin E,selectin E,BSK_LPS_Eselectin_down
339,280,1000000.0,1000000.0,regulation of gene expression,cell adhesion molecules,selectins,SELE,SELE,6401,6401,selectin E,selectin E,BSK_LPS_Eselectin_up
340,281,1000000.0,35.3841710158781,regulation of gene expression,cytokine,interleukins,IL1A,IL1A,3552,3552,"interleukin 1, alpha","interleukin 1, alpha",BSK_LPS_IL1a_down
341,282,1000000.0,1000000.0,regulation of gene expression,cytokine,interleukins,IL1A,IL1A,3552,3552,"interleukin 1, alpha","interleukin 1, alpha",BSK_LPS_IL1a_up
342,283,1000000.0,36.4717485683215,regulation of gene expression,cytokine,interleukins,CXCL8,CXCL8,3576,3576,chemokine (C-X-C motif) ligand 8,chemokine (C-X-C motif) ligand 8,BSK_LPS_IL8_down
343,284,1000000.0,1000000.0,regulation of gene expression,cytokine,interleukins,CXCL8,CXCL8,3576,3576,chemokine (C-X-C motif) ligand 8,chemokine (C-X-C motif) ligand 8,BSK_LPS_IL8_up
344,285,1000000.0,23.239411907127,regulation of gene expression,cytokine,chemotactic factor,CCL2,CCL2,6347,6347,chemokine (C-C motif) ligand 2,chemokine (C-C motif) ligand 2,BSK_LPS_MCP1_down
345,286,1000000.0,1000000.0,regulation of gene expression,cytokine,chemotactic factor,CCL2,CCL2,6347,6347,chemokine (C-C motif) ligand 2,chemokine (C-C motif) ligand 2,BSK_LPS_MCP1_up
346,287,1000000.0,33.0498325062956,regulation of gene expression,cytokine,colony stimulating factor,CSF1,CSF1,1435,1435,colony stimulating factor 1 (macrophage),colony stimulating factor 1 (macrophage),BSK_LPS_MCSF_down
347,288,1000000.0,1000000.0,regulation of gene expression,cytokine,colony stimulating factor,CSF1,CSF1,1435,1435,colony stimulating factor 1 (macrophage),colony stimulating factor 1 (macrophage),BSK_LPS_MCSF_up
348,289,1000000.0,33.8378686945058,regulation of gene expression,gpcr,rhodopsin-like receptor,PTGER2,PTGER2,5732,5732,"prostaglandin E receptor 2 (subtype EP2), 53kDa","prostaglandin E receptor 2 (subtype EP2), 53kDa",BSK_LPS_PGE2_down
349,290,0.298981775959672,1000000.0,regulation of gene expression,gpcr,rhodopsin-like receptor,PTGER2,PTGER2,5732,5732,"prostaglandin E receptor 2 (subtype EP2), 53kDa","prostaglandin E receptor 2 (subtype EP2), 53kDa",BSK_LPS_PGE2_up
350,291,1000000.0,26.6312681223042,cell death,cell cycle,cytotoxicity,,,,,,,BSK_LPS_SRB_down
351,292,1000000.0,1000000.0,cell death,cell morphology,cell conformation,,,,,,,BSK_LPS_SRB_up
352,293,11.6654778662702,34.4437213881519,regulation of gene expression,cytokine,coagulation factor,F3,F3,2152,2152,"coagulation factor III (thromboplastin, tissue factor)","coagulation factor III (thromboplastin, tissue factor)",BSK_LPS_TissueFactor_down
353,294,1000000.0,1000000.0,regulation of gene expression,cytokine,coagulation factor,F3,F3,2152,2152,"coagulation factor III (thromboplastin, tissue factor)","coagulation factor III (thromboplastin, tissue factor)",BSK_LPS_TissueFactor_up
354,295,1000000.0,35.5521440869823,regulation of gene expression,cytokine,inflammatory factor,TNF,TNF,7124,7124,tumor necrosis factor,tumor necrosis factor,BSK_LPS_TNFa_down
355,296,1000000.0,1000000.0,regulation of gene expression,cytokine,inflammatory factor,TNF,TNF,7124,7124,tumor necrosis factor,tumor necrosis factor,BSK_LPS_TNFa_up
356,297,1000000.0,14.0815069711341,regulation of gene expression,cell adhesion molecules,Immunoglobulin CAM,VCAM1,VCAM1,7412,7412,vascular cell adhesion molecule 1,vascular cell adhesion molecule 1,BSK_LPS_VCAM1_down
357,298,1000000.0,1000000.0,regulation of gene expression,cell adhesion molecules,Immunoglobulin CAM,VCAM1,VCAM1,7412,7412,vascular cell adhesion molecule 1,vascular cell adhesion molecule 1,BSK_LPS_VCAM1_up
358,299,22.5736163661492,16.4327936271694,regulation of gene expression,cytokine,other cytokine,CD38,CD38,952,952,CD38 molecule,CD38 molecule,BSK_SAg_CD38_down
359,300,1000000.0,1000000.0,regulation of gene expression,cytokine,other cytokine,CD38,CD38,952,952,CD38 molecule,CD38 molecule,BSK_SAg_CD38_up
360,301,16.263633910241,11.3792302086913,regulation of gene expression,cytokine,inflammatory factor,CD40,CD40,958,958,"CD40 molecule, TNF receptor superfamily member 5","CD40 molecule, TNF receptor superfamily member 5",BSK_SAg_CD40_down
361,302,1000000.0,1000000.0,regulation of gene expression,cytokine,inflammatory factor,CD40,CD40,958,958,"CD40 molecule, TNF receptor superfamily member 5","CD40 molecule, TNF receptor superfamily member 5",BSK_SAg_CD40_up
362,303,17.8747954807527,25.8684940964592,regulation of gene expression,cytokine,inflammatory factor,CD69,CD69,969,969,CD69 molecule,CD69 molecule,BSK_SAg_CD69_down
363,304,1000000.0,1000000.0,regulation of gene expression,cytokine,inflammatory factor,CD69,CD69,969,969,CD69 molecule,CD69 molecule,BSK_SAg_CD69_up
364,305,18.3651638752043,33.7680224581758,regulation of gene expression,cell adhesion molecules,selectins,SELE,SELE,6401,6401,selectin E,selectin E,BSK_SAg_Eselectin_down
365,306,1000000.0,1000000.0,regulation of gene expression,cell adhesion molecules,selectins,SELE,SELE,6401,6401,selectin E,selectin E,BSK_SAg_Eselectin_up
366,307,23.3459509828672,35.5082392430544,regulation of gene expression,cytokine,interleukins,CXCL8,CXCL8,3576,3576,chemokine (C-X-C motif) ligand 8,chemokine (C-X-C motif) ligand 8,BSK_SAg_IL8_down
367,308,1000000.0,1000000.0,regulation of gene expression,cytokine,interleukins,CXCL8,CXCL8,3576,3576,chemokine (C-X-C motif) ligand 8,chemokine (C-X-C motif) ligand 8,BSK_SAg_IL8_up
368,309,16.437897271747,25.102003370166,regulation of gene expression,cytokine,chemotactic factor,CCL2,CCL2,6347,6347,chemokine (C-C motif) ligand 2,chemokine (C-C motif) ligand 2,BSK_SAg_MCP1_down
369,310,1000000.0,1000000.0,regulation of gene expression,cytokine,chemotactic factor,CCL2,CCL2,6347,6347,chemokine (C-C motif) ligand 2,chemokine (C-C motif) ligand 2,BSK_SAg_MCP1_up
370,311,1000000.0,14.913755352482,regulation of gene expression,cytokine,chemotactic factor,CXCL9,CXCL9,4283,4283,chemokine (C-X-C motif) ligand 9,chemokine (C-X-C motif) ligand 9,BSK_SAg_MIG_down
371,312,1000000.0,1000000.0,regulation of gene expression,cytokine,chemotactic factor,CXCL9,CXCL9,4283,4283,chemokine (C-X-C motif) ligand 9,chemokine (C-X-C motif) ligand 9,BSK_SAg_MIG_up
372,313,1000000.0,25.3904451829802,cell death,cell cycle,proliferation,,,,,,,BSK_SAg_PBMCCytotoxicity_down
373,314,1000000.0,1000000.0,cell death,cell cycle,cytotoxicity,,,,,,,BSK_SAg_PBMCCytotoxicity_up
374,315,21.4997925570262,10.8631617197094,cell proliferation,cell cycle,cytotoxicity,,,,,,,BSK_SAg_Proliferation_down
375,316,1000000.0,1000000.0,cell proliferation,cell cycle,proliferation,,,,,,,BSK_SAg_Proliferation_up
376,317,1000000.0,25.1221880207204,cell death,cell cycle,cytotoxicity,,,,,,,BSK_SAg_SRB_down
377,318,1000000.0,1000000.0,cell death,cell morphology,cell conformation,,,,,,,BSK_SAg_SRB_up
378,739,,1000000.0,regulation of gene expression,nuclear receptor,steroidal,AR,AR,367,367,androgen receptor,androgen receptor,OT_AR_ARELUC_AG_1440
379,750,,1000000.0,regulation of gene expression,nuclear receptor,steroidal,ESR1,ESR1,2099,2099,estrogen receptor 1,estrogen receptor 1,OT_ERa_EREGFP_0120
380,751,,1000000.0,regulation of gene expression,nuclear receptor,steroidal,ESR1,ESR1,2099,2099,estrogen receptor 1,estrogen receptor 1,OT_ERa_EREGFP_0480
381,759,1000000.0,1000000.0,regulation of transcription factor activity,background measurement,baseline control,,AR,,367,,androgen receptor,TOX21_AR_BLA_Agonist_ch1
382,760,1000000.0,1000000.0,regulation of transcription factor activity,background measurement,baseline control,,AR,,367,,androgen receptor,TOX21_AR_BLA_Agonist_ch2
383,761,1000000.0,1000000.0,regulation of transcription factor activity,nuclear receptor,steroidal,AR,AR,367,367,androgen receptor,androgen receptor,TOX21_AR_BLA_Agonist_ratio
384,762,1000000.0,33.4377135481714,regulation of transcription factor activity,nuclear receptor,steroidal,AR,AR,367,367,androgen receptor,androgen receptor,TOX21_AR_BLA_Antagonist_ratio
385,763,1000000.0,35.749398622267,cell proliferation,cell cycle,cytotoxicity,,,,,,,TOX21_AR_BLA_Antagonist_viability
386,1202,1000000.0,1000000.0,regulation of transcription factor activity,background measurement,baseline control,,AR,,367,,androgen receptor,TOX21_AR_BLA_Antagonist_ch1
387,1203,1000000.0,1000000.0,regulation of transcription factor activity,background measurement,baseline control,,AR,,367,,androgen receptor,TOX21_AR_BLA_Antagonist_ch2
388,764,1000000.0,1000000.0,regulation of transcription factor activity,nuclear receptor,steroidal,AR,AR,367,367,androgen receptor,androgen receptor,TOX21_AR_LUC_MDAKB2_Agonist
389,765,1000000.0,60.7181950863806,regulation of transcription factor activity,nuclear receptor,steroidal,AR,AR,367,367,androgen receptor,androgen receptor,TOX21_AR_LUC_MDAKB2_Antagonist
390,767,1000000.0,25.8314869919829,regulation of transcription factor activity,cyp,steroidogenesis-related,CYP19A1,CYP19A1,1588,1588,"cytochrome P450, family 19, subfamily A, polypeptide 1","cytochrome P450, family 19, subfamily A, polypeptide 1",TOX21_Aromatase_Inhibition
391,781,1000000.0,1000000.0,regulation of transcription factor activity,hydrolase,atpase,ATAD5,ATAD5,79915,79915,"ATPase family, AAA domain containing 5","ATPase family, AAA domain containing 5",TOX21_ELG1_LUC_Agonist
392,783,1000000.0,1000000.0,regulation of transcription factor activity,background measurement,baseline control,,ESR1,,2099,,estrogen receptor 1,TOX21_ERa_BLA_Agonist_ch1
393,784,1000000.0,1000000.0,regulation of transcription factor activity,background measurement,baseline control,,ESR1,,2099,,estrogen receptor 1,TOX21_ERa_BLA_Agonist_ch2
394,785,1000000.0,1000000.0,regulation of transcription factor activity,nuclear receptor,steroidal,ESR1,ESR1,2099,2099,estrogen receptor 1,estrogen receptor 1,TOX21_ERa_BLA_Agonist_ratio
395,786,58.5232152763657,35.7424731571738,regulation of transcription factor activity,nuclear receptor,steroidal,ESR1,ESR1,2099,2099,estrogen receptor 1,estrogen receptor 1,TOX21_ERa_BLA_Antagonist_ratio
396,787,1000000.0,1000000.0,cell proliferation,cell cycle,cytotoxicity,,,,,,,TOX21_ERa_BLA_Antagonist_viability
397,1189,14.1684505312321,1000000.0,regulation of transcription factor activity,background measurement,baseline control,,ESR1,,2099,,estrogen receptor 1,TOX21_ERa_BLA_Antagonist_ch1
398,1190,1000000.0,1000000.0,regulation of transcription factor activity,background measurement,baseline control,,ESR1,,2099,,estrogen receptor 1,TOX21_ERa_BLA_Antagonist_ch2
399,788,1000000.0,1000000.0,regulation of transcription factor activity,nuclear receptor,steroidal,ESR1,ESR1,2099,2099,estrogen receptor 1,estrogen receptor 1,TOX21_ERa_LUC_BG1_Agonist
400,789,1000000.0,62.4021908634468,regulation of transcription factor activity,nuclear receptor,steroidal,ESR1,ESR1,2099,2099,estrogen receptor 1,estrogen receptor 1,TOX21_ERa_LUC_BG1_Antagonist
401,791,1000000.0,1000000.0,regulation of transcription factor activity,background measurement,baseline control,,NR3C1,,2908,,"nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)",TOX21_GR_BLA_Agonist_ch1
402,792,1000000.0,1000000.0,regulation of transcription factor activity,background measurement,baseline control,,NR3C1,,2908,,"nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)",TOX21_GR_BLA_Agonist_ch2
403,793,1000000.0,1000000.0,regulation of transcription factor activity,nuclear receptor,steroidal,NR3C1,NR3C1,2908,2908,"nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)","nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)",TOX21_GR_BLA_Agonist_ratio
404,794,1000000.0,35.6455792125759,regulation of transcription factor activity,nuclear receptor,steroidal,NR3C1,NR3C1,2908,2908,"nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)","nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)",TOX21_GR_BLA_Antagonist_ratio
405,795,1000000.0,1000000.0,cell proliferation,cell cycle,cytotoxicity,,,,,,,TOX21_GR_BLA_Antagonist_viability
406,1193,1000000.0,1000000.0,regulation of transcription factor activity,background measurement,baseline control,,NR3C1,,2908,,"nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)",TOX21_GR_BLA_Antagonist_ch1
407,1194,1000000.0,42.0689593916405,regulation of transcription factor activity,background measurement,baseline control,,NR3C1,,2908,,"nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)",TOX21_GR_BLA_Antagonist_ch2
408,797,55.0367274610858,13.3856097538959,mitochondrial depolarization,cell morphology,organelle conformation,,,,,,,TOX21_MMP_ratio_down
409,1854,1000000.0,1000000.0,mitochondrial depolarization,cell morphology,organelle conformation,,,,,,,TOX21_MMP_ratio_up
410,799,1000000.0,1000000.0,cell proliferation,cell cycle,cytotoxicity,,,,,,,TOX21_MMP_viability
411,800,1000000.0,1000000.0,regulation of transcription factor activity,background measurement,baseline control,,PPARG,,5468,,peroxisome proliferator-activated receptor gamma,TOX21_PPARg_BLA_Agonist_ch1
412,801,0.0665227438125689,0.0210304670670446,regulation of transcription factor activity,background measurement,baseline control,,PPARG,,5468,,peroxisome proliferator-activated receptor gamma,TOX21_PPARg_BLA_Agonist_ch2
413,802,0.00771151984714819,0.0250063902380938,regulation of transcription factor activity,nuclear receptor,non-steroidal,PPARG,PPARG,5468,5468,peroxisome proliferator-activated receptor gamma,peroxisome proliferator-activated receptor gamma,TOX21_PPARg_BLA_Agonist_ratio
414,803,1000000.0,1000000.0,regulation of transcription factor activity,nuclear receptor,non-steroidal,THRB|THRA,THRB|THRA,7068|7067,7068|7067,"thyroid hormone receptor, beta|thyroid hormone receptor, alpha","thyroid hormone receptor, beta|thyroid hormone receptor, alpha",TOX21_TR_LUC_GH3_Agonist
415,804,77.5137616836278,20.958380917427,regulation of transcription factor activity,nuclear receptor,non-steroidal,THRB|THRA,THRB|THRA,7068|7067,7068|7067,"thyroid hormone receptor, beta|thyroid hormone receptor, alpha","thyroid hormone receptor, beta|thyroid hormone receptor, alpha",TOX21_TR_LUC_GH3_Antagonist
416,806,1000000.0,1000000.0,regulation of transcription factor activity,dna binding,basic helix-loop-helix protein,AHR,AHR,196,196,aryl hydrocarbon receptor,aryl hydrocarbon receptor,TOX21_AhR_LUC_Agonist
417,890,,1000000.0,regulation of catalytic activity,steroid hormone,glucocorticoids,,,,,,,CEETOX_H295R_11DCORT_dn
418,891,,1000000.0,regulation of catalytic activity,steroid hormone,glucocorticoids,,,,,,,CEETOX_H295R_11DCORT_up
419,892,,1000000.0,regulation of catalytic activity,steroid hormone,progestagens,,,,,,,CEETOX_H295R_OHPREG_dn
420,893,,1000000.0,regulation of catalytic activity,steroid hormone,progestagens,,,,,,,CEETOX_H295R_OHPREG_up
421,894,,1000000.0,regulation of catalytic activity,steroid hormone,progestagens,,,,,,,CEETOX_H295R_OHPROG_dn
422,895,,1000000.0,regulation of catalytic activity,steroid hormone,progestagens,,,,,,,CEETOX_H295R_OHPROG_up
423,896,,1000000.0,regulation of catalytic activity,steroid hormone,androgens,,,,,,,CEETOX_H295R_ANDR_dn
424,897,,1000000.0,regulation of catalytic activity,steroid hormone,androgens,,,,,,,CEETOX_H295R_ANDR_up
425,900,,1000000.0,regulation of catalytic activity,steroid hormone,glucocorticoids,,,,,,,CEETOX_H295R_CORTISOL_dn
426,901,,1000000.0,regulation of catalytic activity,steroid hormone,glucocorticoids,,,,,,,CEETOX_H295R_CORTISOL_up
427,904,,1000000.0,regulation of catalytic activity,steroid hormone,glucocorticoids,,,,,,,CEETOX_H295R_DOC_dn
428,905,,1000000.0,regulation of catalytic activity,steroid hormone,glucocorticoids,,,,,,,CEETOX_H295R_DOC_up
429,906,,1000000.0,regulation of catalytic activity,steroid hormone,estrogens,,,,,,,CEETOX_H295R_ESTRADIOL_dn
430,907,,1000000.0,regulation of catalytic activity,steroid hormone,estrogens,,,,,,,CEETOX_H295R_ESTRADIOL_up
431,908,,1000000.0,regulation of catalytic activity,steroid hormone,estrogens,,,,,,,CEETOX_H295R_ESTRONE_dn
432,909,,1000000.0,regulation of catalytic activity,steroid hormone,estrogens,,,,,,,CEETOX_H295R_ESTRONE_up
433,912,,1000000.0,regulation of catalytic activity,steroid hormone,progestagens,,,,,,,CEETOX_H295R_PROG_dn
434,913,,1000000.0,regulation of catalytic activity,steroid hormone,progestagens,,,,,,,CEETOX_H295R_PROG_up
435,914,,1000000.0,regulation of catalytic activity,steroid hormone,androgens,,,,,,,CEETOX_H295R_TESTO_dn
436,915,,1000000.0,regulation of catalytic activity,steroid hormone,androgens,,,,,,,CEETOX_H295R_TESTO_up
437,1108,1000000.0,1000000.0,regulation of transcription factor activity,background measurement,baseline control,,NFE2L2,,4780,,"nuclear factor, erythroid 2-like 2",TOX21_ARE_BLA_Agonist_ch1
438,1109,30.9716204725647,5.19017644340947,regulation of transcription factor activity,background measurement,baseline control,,NFE2L2,,4780,,"nuclear factor, erythroid 2-like 2",TOX21_ARE_BLA_Agonist_ch2
439,1110,47.8128894707636,7.96501881287529,regulation of transcription factor activity,dna binding,basic leucine zipper,NFE2L2,NFE2L2,4780,4780,"nuclear factor, erythroid 2-like 2","nuclear factor, erythroid 2-like 2",TOX21_ARE_BLA_agonist_ratio
440,1185,1000000.0,1000000.0,cell proliferation,cell cycle,cytotoxicity,,,,,,,TOX21_ARE_BLA_agonist_viability
441,1111,1000000.0,1000000.0,regulation of transcription factor activity,background measurement,baseline control,,HSF1,,3297,,heat shock transcription factor 1,TOX21_HSE_BLA_agonist_ch1
442,1112,1000000.0,1000000.0,regulation of transcription factor activity,background measurement,baseline control,,HSF1,,3297,,heat shock transcription factor 1,TOX21_HSE_BLA_agonist_ch2
443,1113,1000000.0,56.5378090648798,regulation of transcription factor activity,dna binding,heat shock protein,HSF1,HSF1,3297,3297,heat shock transcription factor 1,heat shock transcription factor 1,TOX21_HSE_BLA_agonist_ratio
444,1186,1000000.0,1000000.0,cell proliferation,cell cycle,cytotoxicity,,,,,,,TOX21_HSE_BLA_agonist_viability
445,1114,1000000.0,42.5132808700991,regulation of transcription factor activity,background measurement,baseline control,,TP53,,7157,,tumor protein p53,TOX21_p53_BLA_p1_ch1
446,1115,1000000.0,1000000.0,regulation of transcription factor activity,background measurement,baseline control,,TP53,,7157,,tumor protein p53,TOX21_p53_BLA_p1_ch2
447,1116,1000000.0,39.7204084786161,regulation of transcription factor activity,dna binding,tumor suppressor,TP53,TP53,7157,7157,tumor protein p53,tumor protein p53,TOX21_p53_BLA_p1_ratio
448,1187,1000000.0,54.8062125840848,cell proliferation,cell cycle,cytotoxicity,,,,,,,TOX21_p53_BLA_p1_viability
449,1117,1000000.0,1000000.0,regulation of transcription factor activity,background measurement,baseline control,,NR1H4,,9971,,"nuclear receptor subfamily 1, group H, member 4",TOX21_FXR_BLA_agonist_ch1
450,1118,1000000.0,30.65109385445,regulation of transcription factor activity,background measurement,baseline control,,NR1H4,,9971,,"nuclear receptor subfamily 1, group H, member 4",TOX21_FXR_BLA_agonist_ch2
451,1119,1000000.0,1000000.0,regulation of transcription factor activity,nuclear receptor,non-steroidal,NR1H4,NR1H4,9971,9971,"nuclear receptor subfamily 1, group H, member 4","nuclear receptor subfamily 1, group H, member 4",TOX21_FXR_BLA_agonist_ratio
452,1188,1000000.0,1000000.0,cell proliferation,cell cycle,cytotoxicity,,,,,,,TOX21_FXR_BLA_agonist_viability
453,1120,1000000.0,71.0927099474505,regulation of transcription factor activity,nuclear receptor,non-steroidal,NR1H4,NR1H4,9971,9971,"nuclear receptor subfamily 1, group H, member 4","nuclear receptor subfamily 1, group H, member 4",TOX21_FXR_BLA_antagonist_ratio
454,1121,1000000.0,1000000.0,cell proliferation,cell cycle,cytotoxicity,,,,,,,TOX21_FXR_BLA_antagonist_viability
455,1191,1000000.0,252.982203321942,regulation of transcription factor activity,background measurement,baseline control,,NR1H4,,9971,,"nuclear receptor subfamily 1, group H, member 4",TOX21_FXR_BLA_Antagonist_ch1
456,1192,1000000.0,1000000.0,regulation of transcription factor activity,background measurement,baseline control,,NR1H4,,9971,,"nuclear receptor subfamily 1, group H, member 4",TOX21_FXR_BLA_Antagonist_ch2
457,1122,1000000.0,1000000.0,regulation of transcription factor activity,background measurement,baseline control,,PPARD,,5467,,peroxisome proliferator-activated receptor delta,TOX21_PPARd_BLA_agonist_ch1
458,1123,7.00129729293082,126.491105703665,regulation of transcription factor activity,background measurement,baseline control,,PPARD,,5467,,peroxisome proliferator-activated receptor delta,TOX21_PPARd_BLA_agonist_ch2
459,1124,25.8840063498385,1000000.0,regulation of transcription factor activity,nuclear receptor,non-steroidal,PPARD,PPARD,5467,5467,peroxisome proliferator-activated receptor delta,peroxisome proliferator-activated receptor delta,TOX21_PPARd_BLA_agonist_ratio
460,1195,1000000.0,1000000.0,cell proliferation,cell cycle,cytotoxicity,,,,,,,TOX21_PPARd_BLA_Agonist_viability
461,1125,1000000.0,1000000.0,regulation of transcription factor activity,nuclear receptor,non-steroidal,PPARD,PPARD,5467,5467,peroxisome proliferator-activated receptor delta,peroxisome proliferator-activated receptor delta,TOX21_PPARd_BLA_antagonist_ratio
462,1126,1000000.0,1000000.0,cell proliferation,cell cycle,cytotoxicity,,,,,,,TOX21_PPARd_BLA_antagonist_viability
463,1196,1000000.0,1000000.0,regulation of transcription factor activity,background measurement,baseline control,,PPARD,,5467,,peroxisome proliferator-activated receptor delta,TOX21_PPARd_BLA_Antagonist_ch1
464,1197,1000000.0,1000000.0,regulation of transcription factor activity,background measurement,baseline control,,PPARD,,5467,,peroxisome proliferator-activated receptor delta,TOX21_PPARd_BLA_Antagonist_ch2
465,1127,1000000.0,1000000.0,regulation of transcription factor activity,nuclear receptor,non-steroidal,PPARG,PPARG,5468,5468,peroxisome proliferator-activated receptor gamma,peroxisome proliferator-activated receptor gamma,TOX21_PPARg_BLA_antagonist_ratio
466,1128,1000000.0,1000000.0,cell proliferation,cell cycle,cytotoxicity,,,,,,,TOX21_PPARg_BLA_antagonist_viability
467,1198,1000000.0,1000000.0,regulation of transcription factor activity,background measurement,baseline control,,PPARG,,5468,,peroxisome proliferator-activated receptor gamma,TOX21_PPARg_BLA_Antagonist_ch1
468,1199,1000000.0,1000000.0,regulation of transcription factor activity,background measurement,baseline control,,PPARG,,5468,,peroxisome proliferator-activated receptor gamma,TOX21_PPARg_BLA_Antagonist_ch2
469,1129,1000000.0,1000000.0,regulation of transcription factor activity,background measurement,baseline control,,CYP24A1,,1591,,"cytochrome P450, family 24, subfamily A, polypeptide 1",TOX21_VDR_BLA_agonist_ch1
470,1130,26.308026277906,1000000.0,regulation of transcription factor activity,background measurement,baseline control,,CYP24A1,,1591,,"cytochrome P450, family 24, subfamily A, polypeptide 1",TOX21_VDR_BLA_agonist_ch2
471,1131,1000000.0,1000000.0,regulation of transcription factor activity,cyp,xenobiotic metabolism,CYP24A1,CYP24A1,1591,1591,"cytochrome P450, family 24, subfamily A, polypeptide 1","cytochrome P450, family 24, subfamily A, polypeptide 1",TOX21_VDR_BLA_agonist_ratio
472,1331,1000000.0,1000000.0,cell proliferation,cell cycle,cytotoxicity,,,,,,,TOX21_VDR_BLA_Agonist_viability
473,1132,1000000.0,1000000.0,regulation of transcription factor activity,cyp,xenobiotic metabolism,CYP24A1,CYP24A1,1591,1591,"cytochrome P450, family 24, subfamily A, polypeptide 1","cytochrome P450, family 24, subfamily A, polypeptide 1",TOX21_VDR_BLA_antagonist_ratio
474,1133,1000000.0,1000000.0,cell proliferation,cell cycle,cytotoxicity,,,,,,,TOX21_VDR_BLA_antagonist_viability
475,1200,1000000.0,1000000.0,regulation of transcription factor activity,background measurement,baseline control,,CYP24A1,,1591,,"cytochrome P450, family 24, subfamily A, polypeptide 1",TOX21_VDR_BLA_Antagonist_ch1
476,1201,1000000.0,1000000.0,regulation of transcription factor activity,background measurement,baseline control,,CYP24A1,,1591,,"cytochrome P450, family 24, subfamily A, polypeptide 1",TOX21_VDR_BLA_Antagonist_ch2
477,1204,1000000.0,,cell death,cell cycle,cytotoxicity,,,,,,,ATG_XTT_Cytotoxicity_up
478,1315,1000000.0,21.1596455220654,regulation of transcription factor activity,background measurement,baseline control,,TP53,,7157,,tumor protein p53,TOX21_p53_BLA_p2_ch1
479,1316,1000000.0,15.0270593044033,regulation of transcription factor activity,background measurement,baseline control,,TP53,,7157,,tumor protein p53,TOX21_p53_BLA_p2_ch2
480,1317,1000000.0,15.3906079565995,regulation of transcription factor activity,dna binding,tumor suppressor,TP53,TP53,7157,7157,tumor protein p53,tumor protein p53,TOX21_p53_BLA_p2_ratio
481,1318,1000000.0,65.6482206829768,cell proliferation,cell cycle,cytotoxicity,,,,,,,TOX21_p53_BLA_p2_viability
482,1319,1000000.0,26.0215112477891,regulation of transcription factor activity,background measurement,baseline control,,TP53,,7157,,tumor protein p53,TOX21_p53_BLA_p3_ch1
483,1320,1000000.0,19.4987901924582,regulation of transcription factor activity,background measurement,baseline control,,TP53,,7157,,tumor protein p53,TOX21_p53_BLA_p3_ch2
484,1321,1000000.0,25.5667837826703,regulation of transcription factor activity,dna binding,tumor suppressor,TP53,TP53,7157,7157,tumor protein p53,tumor protein p53,TOX21_p53_BLA_p3_ratio
485,1322,1000000.0,73.6661601617852,cell proliferation,cell cycle,cytotoxicity,,,,,,,TOX21_p53_BLA_p3_viability
486,1323,1000000.0,24.6198200148102,regulation of transcription factor activity,background measurement,baseline control,,TP53,,7157,,tumor protein p53,TOX21_p53_BLA_p4_ch1
487,1324,1000000.0,40.9135354295746,regulation of transcription factor activity,background measurement,baseline control,,TP53,,7157,,tumor protein p53,TOX21_p53_BLA_p4_ch2
488,1325,1000000.0,28.0281803378968,regulation of transcription factor activity,dna binding,tumor suppressor,TP53,TP53,7157,7157,tumor protein p53,tumor protein p53,TOX21_p53_BLA_p4_ratio
489,1326,1000000.0,60.3696892322856,cell proliferation,cell cycle,cytotoxicity,,,,,,,TOX21_p53_BLA_p4_viability
490,1327,1000000.0,53.3547507693293,regulation of transcription factor activity,background measurement,baseline control,,TP53,,7157,,tumor protein p53,TOX21_p53_BLA_p5_ch1
491,1328,1000000.0,35.3512584236156,regulation of transcription factor activity,background measurement,baseline control,,TP53,,7157,,tumor protein p53,TOX21_p53_BLA_p5_ch2
492,1329,1000000.0,25.4161895446702,regulation of transcription factor activity,dna binding,tumor suppressor,TP53,TP53,7157,7157,tumor protein p53,tumor protein p53,TOX21_p53_BLA_p5_ratio
493,1330,1000000.0,73.7612850502327,cell proliferation,cell cycle,cytotoxicity,,,,,,,TOX21_p53_BLA_p5_viability
494,1340,1000000.0,1000000.0,regulation of transcription factor activity,background measurement,baseline control,,ATF6,,22926,,activating transcription factor 6,TOX21_ESRE_BLA_ch1
495,1341,1000000.0,1000000.0,regulation of transcription factor activity,background measurement,baseline control,,ATF6,,22926,,activating transcription factor 6,TOX21_ESRE_BLA_ch2
496,1342,1000000.0,1000000.0,regulation of transcription factor activity,dna binding,basic leucine zipper,ATF6,ATF6,22926,22926,activating transcription factor 6,activating transcription factor 6,TOX21_ESRE_BLA_ratio
497,1343,1000000.0,1000000.0,cell proliferation,cell cycle,cytotoxicity,,,,,,,TOX21_ESRE_BLA_viability
498,1344,1000000.0,1000000.0,regulation of transcription factor activity,background measurement,baseline control,,NFKB1,,4790,,nuclear factor of kappa light polypeptide gene enhancer in B-cells 1,TOX21_NFkB_BLA_agonist_ch1
499,1345,1000000.0,1000000.0,regulation of transcription factor activity,background measurement,baseline control,,NFKB1,,4790,,nuclear factor of kappa light polypeptide gene enhancer in B-cells 1,TOX21_NFkB_BLA_agonist_ch2
500,1346,1000000.0,1000000.0,regulation of transcription factor activity,dna binding,NF-kappa B,NFKB1,NFKB1,4790,4790,nuclear factor of kappa light polypeptide gene enhancer in B-cells 1,nuclear factor of kappa light polypeptide gene enhancer in B-cells 1,TOX21_NFkB_BLA_agonist_ratio
501,1347,1000000.0,1000000.0,cell proliferation,cell cycle,cytotoxicity,,,,,,,TOX21_NFkB_BLA_agonist_viability
502,1372,,1000000.0,,,,,,,,,,Tanguay_ZF_120hpf_MORT_up
503,1373,,1000000.0,,,,,,,,,,Tanguay_ZF_120hpf_YSE_up
504,1374,,1000000.0,,,,,,,,,,Tanguay_ZF_120hpf_AXIS_up
505,1375,,1000000.0,,,,,,,,,,Tanguay_ZF_120hpf_EYE_up
506,1376,,1000000.0,,,,,,,,,,Tanguay_ZF_120hpf_SNOU_up
507,1377,,1000000.0,,,,,,,,,,Tanguay_ZF_120hpf_JAW_up
508,1378,,1000000.0,,,,,,,,,,Tanguay_ZF_120hpf_OTIC_up
509,1379,,1000000.0,,,,,,,,,,Tanguay_ZF_120hpf_PE_up
510,1380,,1000000.0,,,,,,,,,,Tanguay_ZF_120hpf_BRAI_up
511,1381,,1000000.0,,,,,,,,,,Tanguay_ZF_120hpf_SOMI_up
512,1382,,1000000.0,,,,,,,,,,Tanguay_ZF_120hpf_PFIN_up
513,1383,,1000000.0,,,,,,,,,,Tanguay_ZF_120hpf_CFIN_up
514,1384,,1000000.0,,,,,,,,,,Tanguay_ZF_120hpf_PIG_up
515,1385,,1000000.0,,,,,,,,,,Tanguay_ZF_120hpf_CIRC_up
516,1386,,1000000.0,,,,,,,,,,Tanguay_ZF_120hpf_TRUN_up
517,1387,,1000000.0,,,,,,,,,,Tanguay_ZF_120hpf_SWIM_up
518,1388,,1000000.0,,,,,,,,,,Tanguay_ZF_120hpf_NC_up
519,1389,,1000000.0,,,,,,,,,,Tanguay_ZF_120hpf_TR_up
520,1797,,1000000.0,,,,,,,,,,Tanguay_ZF_120hpf_ActivityScore
521,1507,,1.35949582720966,,,,,,,,,,NHEERL_ZF_144hpf_TERATOSCORE_up
522,1509,,17.8394570397831,cytotoxicity,cell cycle,cytotoxicity,,,,,,,NCCT_HEK293T_CellTiterGLO
